{"study_id": 62799, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of a nutraceutical combination containing Coenzyme Q10 against acupuncture in treating fibromyalgia syndrome (FMS) symptoms.", "results_summary": "The study found that the nutraceutical approach (Migratens) showed significant improvements in pain, fatigue, sleep, and cognitive disturbances in FMS patients compared to baseline, though direct comparison to acupuncture was not fully detailed in the abstract.", "population_specificity": "60 female patients with fibromyalgia syndrome (FMS).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:59.586247+00:00"}
{"study_id": 62802, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the beneficial effects of Coenzyme Q10 on oxidative stress and antioxidant response in diabetic nephropathy.", "results_summary": "The study suggests Coenzyme Q10, among other dietary antioxidants, has beneficial effects on oxidative stress and antioxidant capacity in diabetic nephropathy, potentially offering positive clinical impacts.", "population_specificity": "Individuals with diabetes and diabetic nephropathy (experimental and human models).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:00.869246+00:00"}
{"study_id": 62803, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to identify biomarkers, including Coenzyme Q10, that could aid in diagnosing multiple system atrophy (MSA) and differentiating it from Parkinson's disease (PD).", "results_summary": "The study found that reduced levels of Coenzyme Q10 in plasma were associated with MSA, suggesting its potential as a diagnostic biomarker. However, the abstract does not detail the magnitude or clinical significance of this reduction.", "population_specificity": "Adults with multiple system atrophy (MSA) and healthy controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:03.251755+00:00"}
{"study_id": 62804, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize recent findings on neuroprotective substances, including Coenzyme Q10, focusing on their mechanisms of action, bioavailability, and safety for humans.", "results_summary": "The abstract highlights Coenzyme Q10 as a promising endogenous substance for reducing and postponing clinical manifestations of neurodegenerative diseases, emphasizing its neuroprotective properties when present in sufficient concentrations in the central nervous system.", "population_specificity": "General discussion on neurodegenerative diseases (e.g., Alzheimer's, Parkinson's) without specifying a particular study population.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:04.079804+00:00"}
{"study_id": 62805, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of a liquid food supplement containing water-soluble Coenzyme Q10 (Q10Vital\u00ae) and collagen on dermal density and other skin parameters in comparison to placebo.", "results_summary": "The study compared the effects of the test product (Coenzyme Q10 and collagen) to placebo in healthy women, focusing on dermal density and skin parameters, but specific results were not detailed in the abstract.", "population_specificity": "34 healthy women aged 40-65.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:05.630856+00:00"}
{"study_id": 62807, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to summarize the available data on the potential cardiovascular protective effects of dietary supplements, including Coenzyme Q10.", "results_summary": "The abstract mentions preliminary evidence of cardiovascular protection with Coenzyme Q10, but the level of scrutiny and evidence remains unclear compared to pharmacological therapies.", "population_specificity": "Not specified (general cardiovascular disease context)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:06.427941+00:00"}
{"study_id": 62806, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of Coenzyme Q10 on inflammation markers and clinical outcomes in septic patients during the early phase of sepsis.", "results_summary": "CoQ10 administration significantly reduced TNF-\u03b1 and MDA levels by the 7th day and was associated with lower in-hospital mortality compared to the control group. The study suggests CoQ10 improves clinical parameters and mitochondrial dysfunction in early sepsis.", "population_specificity": "Septic patients (n=40) in the early phase of sepsis.", "effective_dosage": "100 mg twice daily.", "study_duration": "7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:06.588839+00:00"}
{"study_id": 62809, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the biological and pharmacological activities of Coenzyme Q10 in preventing and treating hypertension.", "results_summary": "The study suggests that Coenzyme Q10, among other nutraceuticals, may help regulate blood pressure by modulating risk factors such as oxidative stress and vascular resistance. However, specific efficacy data for Coenzyme Q10 alone are not detailed in the abstract.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:07.185364+00:00"}
{"study_id": 62808, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the role of Coenzyme Q10 as an adjuvant treatment in improving pregnancy outcomes for poor responders undergoing IVF.", "results_summary": "CoQ10 significantly increased the chance of clinical pregnancy (OR 2.22, 95% CI 1.08-4.58) and resulted in the lowest global cancellation rate (OR 0.33, 95% CI 0.15-0.74) compared to controls.", "population_specificity": "Women with poor ovarian response (POR) undergoing IVF.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:07.516265+00:00"}
{"study_id": 62810, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to design a micellar nanocarrier of Coenzyme Q10 to improve its delivery for treating periodontal diseases.", "results_summary": "The abstract does not provide results regarding Coenzyme Q10's effects, only stating the study's aim.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:07.758410+00:00"}
{"study_id": 62812, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether antioxidant supplements, including Coenzyme Q10, were associated with breast cancer recurrence and survival outcomes during chemotherapy.", "results_summary": "The study found that antioxidant supplement use, including Coenzyme Q10, was associated with an increased hazard of recurrence (adjHR 1.41), suggesting potential negative effects during chemotherapy.", "population_specificity": "Patients with breast cancer undergoing chemotherapy (n = 1,134).", "effective_dosage": "Not specified", "study_duration": "Supplement use was assessed at registration and during treatment (exact duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:11.441307+00:00"}
{"study_id": 62813, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the short-term effect of topically applied CoQ10 on retina and choroid in Alzheimer's disease patients.", "results_summary": "CoQ10 treatment increased retinal nerve fiber layer thickness in all quadrants, with significant rises in average and temporal quadrant thickness, and improved ganglion cell-inner plexiform layer thickness. The improvements were inversely correlated with disease duration and severity.", "population_specificity": "62 Alzheimer's disease patients (30 treated, 32 untreated) and 31 healthy controls.", "effective_dosage": "Not specified", "study_duration": "Short-term (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:12.415962+00:00"}
{"study_id": 62815, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy and safety of Coenzyme Q10 as a nutraceutical intervention for improving clinical and biological outcomes in people with multiple sclerosis.", "results_summary": "The study found that Coenzyme Q10 improved biological and/or clinical outcomes in multiple sclerosis compared to control, though the trial was small and lacked replication.", "population_specificity": "People with multiple sclerosis", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:13.324681+00:00"}
{"study_id": 62819, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore new approaches in atherosclerosis treatment, including the potential role of Coenzyme Q10 in addressing cellular-level arterial damage factors like inflammation and mitochondrial dysfunction.", "results_summary": "The abstract does not provide specific results regarding Coenzyme Q10's effects, only highlighting the need for new treatment approaches in atherosclerosis.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:14.524353+00:00"}
{"study_id": 62814, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether ubiquinol (a reduced form of CoQ10) improves peripheral endothelial function in patients with heart failure with reduced ejection fraction (HFrEF).", "results_summary": "Ubiquinol 400 mg/day for 3 months significantly improved peripheral endothelial function as measured by RHI (p=0.026) and showed a trend toward improvement in LnRHI (p=0.076), while placebo had no significant effect.", "population_specificity": "Patients with stable HFrEF (n=14).", "effective_dosage": "400 mg/day.", "study_duration": "3 months per treatment phase (with a 1-month washout).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:14.541343+00:00"}
{"study_id": 62816, "supplement_id": 1036, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine whether CoQ10 supplementation could improve clinical symptoms like myalgia and pain in statin-intolerant patients while maintaining statin therapy at half dosage.", "results_summary": "CoQ10 supplementation reduced myalgia symptoms (Clinical Index Score and VAS) and showed an inverse correlation with CPK levels, while placebo had no effect. The study concluded that CoQ10 improved symptom perception in statin-intolerant patients.", "population_specificity": "60 Caucasian patients with statin intolerance.", "effective_dosage": "100 mg/day (liquid supplement).", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:14.673865+00:00"}
{"study_id": 62821, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to review the potential synergistic effects of selenium and Coenzyme Q10 co-supplementation in critically ill patients, focusing on cellular energy supply and oxidative stress.", "results_summary": "The abstract does not provide specific results but suggests that previous studies on selenium supplementation in critical illness have reported variable outcomes, and the interaction with Coenzyme Q10 has not been explored.", "population_specificity": "Critically ill patients with multiple organ dysfunction.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:15.272966+00:00"}
{"study_id": 62823, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the evidence for integrative therapies, including Coenzyme Q10, in managing cancer-related fatigue (CRF) during and after cancer treatment.", "results_summary": "The study found insufficient evidence to recommend Coenzyme Q10 for CRF during active cancer treatment, and it was explicitly not recommended for this phase.", "population_specificity": "Cancer patients experiencing cancer-related fatigue (CRF).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:20.036607+00:00"}
{"study_id": 62824, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the evidence for Coenzyme Q10's benefits in Huntington's disease, focusing on its efficacy and safety.", "results_summary": "The study found no evidence supporting disease modification or symptom improvement with Coenzyme Q10 for Huntington's disease. Few studies met high levels of evidence for benefits.", "population_specificity": "Individuals with Huntington's disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:20.168483+00:00"}
{"study_id": 62825, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether CoQ10 affects platelet integrin \u03b1IIb\u03b23 signaling and thrombosis, a major cause of cardiovascular diseases.", "results_summary": "CoQ10 reduced human platelet aggregation, granule secretion, spreading, and clot retraction by inhibiting integrin \u03b1IIb\u03b23 outside-in signaling, primarily through upregulation of the cAMP/PKA pathway. These effects suggest a protective role against thrombosis in cardiovascular disease risk patients.", "population_specificity": "Human platelets (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:21.501673+00:00"}
{"study_id": 62827, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to review the potential role of CoQ10 supplementation in treating tissue fibrosis, particularly in age-related cardiovascular dysfunction.", "results_summary": "The study suggests CoQ10 supplementation may reduce cardiovascular fibrosis in older individuals, improving cardiovascular function and lowering associated mortality risk, likely due to its antioxidant and anti-inflammatory properties.", "population_specificity": "Older individuals with age-related cardiovascular fibrosis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:21.637235+00:00"}
{"study_id": 62826, "supplement_id": 1036, "safety_score": "80", "efficacy_score": 30, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the therapeutic effects of Coenzyme Q10 in patients with Duchenne muscular dystrophy.", "results_summary": "Coenzyme Q10 had a minor effect on a few functions in Duchenne muscular dystrophy patients, with no reported adverse reactions. The impact was limited and not clinically significant.", "population_specificity": "Patients with Duchenne muscular dystrophy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:21.638951+00:00"}
{"study_id": 62828, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential of Coenzyme Q10 as an antioxidant therapy for chronic heart failure, focusing on its role in mitigating oxidative stress and inflammation.", "results_summary": "The abstract suggests that Coenzyme Q10, alongside vitamin C and elamipretide, showed promising results in clinical trials for chronic heart failure, unlike other antioxidants with disappointing outcomes. It highlights its potential as an adjunct therapy for reducing oxidative stress and inflammation in heart failure patients.", "population_specificity": "Patients with chronic heart failure, particularly those with enhanced oxidative stress and inflammation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:22.988406+00:00"}
{"study_id": 62829, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the effect of CoQ10 supplementation on serum matrix metalloproteinases (MMPs) and clinical parameters in rheumatoid arthritis (RA) patients.", "results_summary": "CoQ10 supplementation significantly reduced serum MMP-3 levels and improved clinical outcomes (DAS-28, pain score, swollen/tender joint count) compared to placebo, suggesting potential benefits for RA patients. Both groups showed reductions in MMP-1 and swollen joint count, but CoQ10 had additional significant improvements in ESR, pain score, and tender joint count.", "population_specificity": "54 RA patients (18-56 years, diagnosed \u22656 months, DAS-28 > 3.2).", "effective_dosage": "100 mg/day", "study_duration": "2 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:24.825251+00:00"}
{"study_id": 62830, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to determine whether CoQ10 supplementation reduces pain better than pregabalin alone in fibromyalgia patients.", "results_summary": "The abstract does not provide specific results but suggests CoQ10 may reduce pain in fibromyalgia patients treated with pregabalin, though the effects on anxiety, brain activity, oxidative stress, antioxidants, and inflammation remain unclear.", "population_specificity": "Pregabalin-treated fibromyalgia patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:27.600983+00:00"}
{"study_id": 62831, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential negative impact of statins on Coenzyme Q10 synthesis and its implications for heart failure progression.", "results_summary": "The study suggests that high doses of statins may worsen heart failure by inhibiting CoQ10 synthesis and intensifying hypertrophy, despite their other positive effects.", "population_specificity": "Patients with long-term heart failure, particularly those on statin therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Statins (specifically mentioned as inhibiting CoQ10 synthesis)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:28.859586+00:00"}
{"study_id": 62834, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 15, "quality_score": 75, "study_goal": "The researchers aimed to assess the effects of Coenzyme Q10 supplementation on body weight and body mass index (BMI) in patients through a meta-analysis of randomized controlled clinical trials.", "results_summary": "The meta-analysis found no significant effect of Coenzyme Q10 supplementation on body weight or BMI, with subgroup analysis indicating that dosage and trial duration did not influence the results.", "population_specificity": "Patients in randomized controlled clinical trials (specific conditions not detailed in the abstract).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:30.012599+00:00"}
{"study_id": 62833, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of CoQ10 (alone or combined with vitamin E) on cardiometabolic outcomes in women with PCOS.", "results_summary": "CoQ10 and/or vitamin E significantly reduced triglycerides, and their combination also lowered total cholesterol, LDL-C, and improved other lipid markers. The supplements also positively affected blood pressure and adiposity indices.", "population_specificity": "86 women with polycystic ovary syndrome (PCOS).", "effective_dosage": "Not specified in the abstract.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:30.411052+00:00"}
{"study_id": 62836, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the feasibility and utility of Coenzyme Q10 as a nutraceutical agent for lowering lipoprotein (a) levels to improve cardiovascular outcomes.", "results_summary": "The study found that Coenzyme Q10 is a promising clinical candidate for lowering Lp(a) levels, warranting further exploration for clinical applicability, though definitive long-term trials are needed.", "population_specificity": "Not specified (general cardiovascular risk population inferred)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:31.285628+00:00"}
{"study_id": 62832, "supplement_id": 1036, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of a nutraceutical combination containing Coenzyme Q10 in improving lipid profiles and glucose levels in pre-hypertensive, hypercholesterolemic subjects.", "results_summary": "The study found that the nutraceutical combination significantly improved lipid profiles (reduced TC, LDLC, TG, and increased HDLC) and glucose levels, with no significant changes in BP or BMI. Safety was confirmed, with no adverse effects reported.", "population_specificity": "Hypercholesterolemic subjects with pre-hypertension (systolic BP 130-139 mmHg and/or diastolic BP 85-89 mmHg) without organ damage or history of cardiovascular diseases.", "effective_dosage": "Once-daily oral formulation (specific dosage of Coenzyme Q10 not detailed).", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:33.130723+00:00"}
{"study_id": 62838, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to quantitatively pool data on blood oxidative stress marker levels in ALS patients compared to normal controls.", "results_summary": "The meta-analysis included 41 studies with 4,588 ALS patients and 6,344 controls, analyzing 15 oxidative stress markers. Results indicated elevated malondialdehyde levels in ALS patients, suggesting increased oxidative stress.", "population_specificity": "Patients with amyotrophic lateral sclerosis (ALS) and normal controls.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:35.406178+00:00"}
{"study_id": 62839, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of Coenzyme Q10 as an alternate prophylactic medication for adults with moderate-to-severe cyclic vomiting syndrome (CVS).", "results_summary": "The study conditionally recommended Coenzyme Q10, along with other mitochondrial supplements, as an alternate prophylactic medication for CVS, either alone or in combination with other treatments. No specific efficacy data or outcomes for Coenzyme Q10 were detailed in the abstract.", "population_specificity": "Adults with moderate-to-severe cyclic vomiting syndrome (CVS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:37.322405+00:00"}
{"study_id": 62820, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 40, "study_goal": "The researchers were examining the potential link between statin therapy, Coenzyme Q10 reduction, and the development of peripheral neuropathy.", "results_summary": "The study found that statin therapy, particularly with lipophilic statins like atorvastatin, leads to a significant reduction in Coenzyme Q10 levels, which may impair neuronal energy and contribute to peripheral neuropathy. The incidence of polyneuropathy was higher with atorvastatin (65%) compared to fluvastatin (54%).", "population_specificity": "Patients on long-term statin therapy (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Long-term (specific duration not provided)", "interactions": "Statins (atorvastatin, simvastatin, fluvastatin)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:38.885324+00:00"}
{"study_id": 62841, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness of CoQ10 combined with other western medicine for treating diabetic kidney disease (DKD) through randomized controlled trials (RCTs) and experimental studies.", "results_summary": "CoQ10 combined with other western medicine showed statistical improvements in fasting plasma glucose, HbA1c, cholesterol levels, and oxidative stress markers, but no significant benefits were observed for LDL-C, urea, urine output, or glucose in some studies. The conclusion urged caution and called for more rigorous future studies.", "population_specificity": "Patients with diabetic kidney disease (DKD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:39.088517+00:00"}
{"study_id": 62843, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review potential therapeutic strategies, including supplements like Coenzyme Q10, for targeting oxidative stress, mitochondrial dysfunction, and other pathologies in Alzheimer's disease.", "results_summary": "The abstract does not provide specific findings on Coenzyme Q10 but highlights the need for safe, long-term treatments that reduce oxidative stress and improve neuronal energy levels.", "population_specificity": "Not specified (general focus on neurodegenerative diseases like Alzheimer's).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:39.296318+00:00"}
{"study_id": 62844, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to explore the potential role of Coenzyme Q10, among other bioactive compounds, in improving atheroma plaque inflammation as part of atherosclerosis management.", "results_summary": "The abstract suggests that Coenzyme Q10, along with other dietary supplements and bioactive compounds, has been associated with improvements in atheroma plaque inflammation, though many correlations remain preliminary.", "population_specificity": "Not specified (general atherosclerosis/CVD context implied).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:40.505606+00:00"}
{"study_id": 62837, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate the neuroprotective effects of CoQ10 and Vitamin E in patients with primary open-angle glaucoma (POAG) under prostaglandin analogue monotherapy.", "results_summary": "The abstract does not provide results, as it describes a planned study rather than reporting outcomes.", "population_specificity": "POAG patients with intraocular pressure (IOP) between 17-21 mm Hg on prostaglandin analogue monotherapy and specific visual field criteria.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:42.130382+00:00"}
{"study_id": 62845, "supplement_id": 1036, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to determine whether ubiquinol (reduced Coenzyme Q10) could improve saliva secretion and related symptoms in individuals with slight mouth dryness.", "results_summary": "Ubiquinol significantly increased saliva flow rate and CoQ10 levels in saliva, improved subjective symptoms (e.g., tiredness, mouth dryness), and showed no serious adverse events. In vitro, it boosted ATP production and reduced oxidative stress in salivary gland cells.", "population_specificity": "40 healthy subjects aged \u226465 years with slight mouth dryness (18 in ubiquinol group, 20 in placebo group).", "effective_dosage": "50 mg ubiquinol twice daily (via gummy candy).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:44.967885+00:00"}
{"study_id": 62849, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the clinical trial data supporting Coenzyme Q10 supplementation in patients with heart failure.", "results_summary": "The abstract notes that Coenzyme Q10 has some clinical trial data supporting its supplementation in heart failure patients, but evidence for therapeutic repletion remains limited.", "population_specificity": "Patients with heart failure.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:46.506230+00:00"}
{"study_id": 62848, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to determine whether CoQ10 supplementation could improve left ventricle diastolic function in patients with heart failure with preserved ejection fraction (HFpEF).", "results_summary": "The study found no statistically significant improvement in LV diastolic function with short-term CoQ10 supplementation compared to the control group, as measured by E/e' and LAVI.", "population_specificity": "30 patients with HFpEF (28 completed the study).", "effective_dosage": "100 mg three times a day.", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:46.760191+00:00"}
{"study_id": 62847, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to analyze preclinical evidence on the influence of Coenzyme Q10 and other nutrients on the pathogenesis of pulmonary arterial hypertension (PAH).", "results_summary": "The study suggests that Coenzyme Q10 may influence various aspects of PAH pathobiology, but evidence on its role in humans is limited. Further research is needed to determine its efficacy in improving PAH outcomes.", "population_specificity": "Preclinical studies (not specified if human or animal models).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:47.094126+00:00"}
{"study_id": 62846, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to systematically review interventional studies to determine the effects of CoQ10 supplementation on fatigue in adolescent and adult populations.", "results_summary": "Among 16 included studies, 10 showed significant beneficial effects of CoQ10 on fatigue in healthy individuals and those with fibromyalgia, statin-related fatigue, multiple sclerosis, and end-stage heart failure. CoQ10 appeared most effective for statin-related fatigue and fibromyalgia, but more clinical trials are needed for conclusive evidence.", "population_specificity": "Adolescents and adults, including healthy individuals and those with fibromyalgia, statin-related fatigue, multiple sclerosis, and end-stage heart failure.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:47.294983+00:00"}
{"study_id": 62850, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the therapeutic properties of Coenzyme Q10, particularly its encapsulation in micro- and nano-delivery systems to enhance its efficacy and stability.", "results_summary": "The study found that encapsulation of Coenzyme Q10 in micro- and nano-delivery systems improved its solubility, chemical stability, and prolonged its antioxidant effects, enhancing bioavailability and release kinetics. Encapsulated antioxidants, including Coenzyme Q10, showed potential in inhibiting cancer cell proliferation and suppressing cancer progression.", "population_specificity": "Not specified (in vitro and in vivo studies mentioned, but no human population details provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:49.454103+00:00"}
{"study_id": 62851, "supplement_id": 1036, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to assess the consistency of CoQ10's treatment effect in the European sub-population of the Q-SYMBIO trial, focusing on its impact on heart failure outcomes.", "results_summary": "CoQ10 significantly reduced major adverse cardiovascular events (MACE), all-cause and cardiovascular mortality, and improved NYHA classification and left ventricular ejection fraction (LVEF) compared to placebo. No significant changes were observed in short-term endpoints.", "population_specificity": "Patients with moderate to severe chronic heart failure in the European sub-population of the Q-SYMBIO trial.", "effective_dosage": "300 mg daily", "study_duration": "2 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:51.048850+00:00"}
{"study_id": 62852, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to explore the plasma concentration levels of a novel CoQ10 oral preparation (COQUN).", "results_summary": "The abstract does not provide specific results regarding Coenzyme Q10's effects, only stating the study's intent to explore bioavailability.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:51.505183+00:00"}
{"study_id": 62853, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential of Coenzyme Q10 as an exogenous antioxidant to ameliorate oxidative stress in dialysis patients.", "results_summary": "The abstract suggests that Coenzyme Q10, among other antioxidants, has been studied for its potential to counteract oxidative stress in dialysis patients, but specific results regarding its effectiveness are not detailed.", "population_specificity": "End-stage renal disease patients on hemodialysis (HD) or peritoneal dialysis (PD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:54.162580+00:00"}
{"study_id": 62855, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antidepressant effects of adjunctive anti-inflammatory agents, including Coenzyme Q10, in the treatment of bipolar depression.", "results_summary": "The study found that Coenzyme Q10 demonstrated antidepressant effects when used as an adjunctive treatment in bipolar depression, alongside other anti-inflammatory agents like NAC, pioglitazone, and minocycline. The evidence for Coenzyme Q10 was part of a broader trend showing moderate effect sizes and good tolerability for anti-inflammatory agents in this context.", "population_specificity": "Patients with bipolar disorder, specifically during the depressive phase.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:55.643103+00:00"}
{"study_id": 62854, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of CoQ10 supplementation on biomarkers of inflammation and oxidative stress in patients with coronary artery disease (CAD).", "results_summary": "CoQ10 supplementation significantly increased superoxide dismutase (SOD) and catalase (CAT) levels while reducing malondialdehyde (MDA) and diene levels, but it did not affect C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-\u03b1), interleukin-6 (IL-6), or glutathione peroxidase (GPx) levels in CAD patients.", "population_specificity": "Patients with coronary artery disease (CAD).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:55.845232+00:00"}
{"study_id": 62857, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of a nutraceutical combination containing Coenzyme Q10 on endothelial function, lipid profile, and glucose metabolism in dyslipidemic subjects.", "results_summary": "The study found that the nutraceutical combination containing Coenzyme Q10 improved lipid profile, but specific effects attributable solely to Coenzyme Q10 were not isolated in the abstract.", "population_specificity": "Fifty subjects with dyslipidemia not requiring statin treatment.", "effective_dosage": "2 mg Coenzyme Q10 (as part of a combination supplement).", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:55.920426+00:00"}
{"study_id": 62858, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to explore whether natural products, including Coenzyme Q10, could serve as a therapeutic option for reducing elevated lipoprotein(a) levels in hyperlipidemic patients.", "results_summary": "The abstract suggests that Coenzyme Q10, among other natural products, has been studied in preclinical and clinical settings for its potential to lower lipoprotein(a) levels, but specific efficacy data are not detailed.", "population_specificity": "Hyperlipidemic patients with elevated lipoprotein(a) levels.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:57.445528+00:00"}
{"study_id": 62860, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to highlight the relevance of drug-micronutrient interactions, using Coenzyme Q10 as an example, to sensitize physicians and pharmacists.", "results_summary": "The abstract does not provide specific findings about Coenzyme Q10's effects but emphasizes the importance of understanding drug-micronutrient interactions broadly.", "population_specificity": "Not specified", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:58.179037+00:00"}
{"study_id": 62859, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate whether Coenzyme Q10 improves semen parameters and pregnancy rates in men with idiopathic infertility.", "results_summary": "The study found that Coenzyme Q10 improved semen parameters, but there was limited evidence regarding its impact on pregnancy or live birth rates. The certainty of evidence was very low due to methodological flaws and inconsistencies.", "population_specificity": "Men with idiopathic infertility.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:58.510057+00:00"}
{"study_id": 62862, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess the impact of a dietary intervention with specific micronutrients, including Coenzyme Q10, on lowering insulin resistance levels and improving left ventricular function in patients with cardiac arrhythmias.", "results_summary": "The dietary intervention with micronutrients, including Coenzyme Q10, significantly reduced fasting insulin and HOMA-IR, and improved left ventricular diastolic function, but did not reduce premature beats.", "population_specificity": "Patients aged 18-75 with cardiac arrhythmias (VPBs, SVPBs, SV tachycardia) recruited from an outpatient cardiology practice.", "effective_dosage": "Not specified", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:02.651689+00:00"}
{"study_id": 62865, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of Coenzyme Q10 supplementation on metabolic profiles in patients with Chronic Kidney Disease (CKD).", "results_summary": "CoQ10 supplementation significantly reduced total cholesterol, LDL-cholesterol, malondialdehyde (MDA), and creatinine levels in CKD patients but had no effect on triglycerides, HDL-cholesterol, fasting glucose, insulin, HOMA-IR, or CRP concentrations.", "population_specificity": "Patients diagnosed with Chronic Kidney Disease (CKD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:04.068419+00:00"}
{"study_id": 62863, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Coenzyme Q10 supplementation could improve sperm quality parameters, such as concentration, motility, and morphology, in the context of male fertility.", "results_summary": "The study found that Coenzyme Q10 supplementation significantly increased total sperm concentration (5.93 \u00d7 10^6 spz/mL), sperm count (10.15 \u00d7 10^6 spz/mL), sperm total motility (5.30%), and sperm morphology (1.06%).", "population_specificity": "Men with fertility issues (specific demographics not detailed in the abstract).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:04.330174+00:00"}
{"study_id": 62866, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether statin treatment reduces circulating Coenzyme Q10 (CoQ10) levels and whether this effect varies by statin type, intensity, or treatment duration.", "results_summary": "The study found that statin treatment significantly decreased circulating CoQ10 levels, regardless of statin type (lipophilic or hydrophilic), intensity (low-middle or high), or treatment duration. The findings suggest a potential mechanism for statin-associated muscle symptoms (SAMS) and indicate that CoQ10 supplementation may help mitigate these effects.", "population_specificity": "1,776 participants across 12 randomized controlled trials.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "Statin treatment (both lipophilic and hydrophilic) was noted to reduce CoQ10 levels.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:05.791840+00:00"}
{"study_id": 62867, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to assess the effect of liquid ubiquinol supplementation on cardiac function in children with pediatric dilated cardiomyopathy (PDCM).", "results_summary": "Liquid ubiquinol supplementation significantly improved ejection fraction (EF) and fractional shortening (FS) until week 16, with higher plasma CoQ10 levels correlating to better cardiac function. Additionally, 30% of subjects showed improvement in NYHA heart failure classification after 24 weeks.", "population_specificity": "Children diagnosed with pediatric dilated cardiomyopathy (PDCM).", "effective_dosage": "10 mg/kg body weight/day.", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:05.860362+00:00"}
{"study_id": 62870, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review the evidence behind lifestyle modifications, including supplements like Coenzyme Q10, and their potential impact on the epidemiology, pathophysiology, etiology, and management of stage A heart failure.", "results_summary": "The abstract does not provide specific findings regarding Coenzyme Q10's effects, as it broadly reviews multiple lifestyle factors without detailing results for individual supplements.", "population_specificity": "Patients with or at risk for stage A heart failure.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:06.683727+00:00"}
{"study_id": 62869, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether CoQ10 supplementation enhances the anti-inflammatory effects of Simvastatin therapy in patients at risk for cardiovascular disease.", "results_summary": "CoQ10 supplementation showed no significant effect on inflammatory markers or lipids in patients on Simvastatin therapy, though it may improve glucose homeostasis. Simvastatin alone reduced certain inflammatory markers compared to untreated controls.", "population_specificity": "35 patients in primary prevention for cardiovascular disease on Simvastatin (40 mg/day), plus 20 untreated hypercholesterolemic controls.", "effective_dosage": "400 mg/day of CoQ10", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:07.221513+00:00"}
{"study_id": 62871, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Coenzyme Q10 supplementation alleviates statin-induced myopathy symptoms.", "results_summary": "CoQ10 supplementation significantly improved statin-associated muscle symptoms (pain, weakness, cramps, tiredness) but did not reduce plasma creatine kinase levels.", "population_specificity": "575 patients (294 in CoQ10 group, 281 in placebo group) with statin-induced myopathy.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:10.743779+00:00"}
{"study_id": 62873, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review the history, chemical structure, sources, and effects of Coenzyme Q10, focusing on its oral applications for skin health and aging.", "results_summary": "The abstract does not provide specific findings on Coenzyme Q10's effects, as it is a general review covering multiple compounds.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:11.401322+00:00"}
{"study_id": 62872, "supplement_id": 1036, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness of ubiquinol versus ubiquinone supplements in enhancing CoQ10 status in older men.", "results_summary": "Ubiquinol supplementation significantly increased plasma ubiquinone and total CoQ10 levels, while ubiquinone had insignificant effects. Neither form altered oxidative stress biomarkers or CoQ10 status in PBMCs.", "population_specificity": "Older men", "effective_dosage": "200 mg per day with one main meal", "study_duration": "2 weeks per intervention phase, with a 2-week washout", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:11.798851+00:00"}
{"study_id": 62875, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of Coenzyme Q10 supplementation on lipid profile in patients with coronary artery disease (CAD).", "results_summary": "CoQ10 supplementation significantly decreased total cholesterol and increased HDL-cholesterol levels in CAD patients but had no significant effect on LDL-cholesterol, triglycerides, or lipoprotein (a) levels.", "population_specificity": "Patients diagnosed with coronary artery disease (CAD).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:13.768997+00:00"}
{"study_id": 62876, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential benefits of Coenzyme Q10 in alleviating symptoms of atypical parkinsonian syndromes.", "results_summary": "The study found that Coenzyme Q10, along with other treatments, showed some benefits in alleviating symptoms in atypical parkinsonisms, though the extent of its efficacy was not detailed.", "population_specificity": "Patients with atypical parkinsonian syndromes (PSP, CBD, MSA, PDD, LBD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:14.294911+00:00"}
{"study_id": 62874, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether statin-induced myalgia is linked to reduced intramuscular CoQ10 levels and impaired mitochondrial respiratory function.", "results_summary": "The study found no difference in intramuscular CoQ10 levels between groups, but statin therapy impaired mitochondrial complex II-linked respiration. Myalgia was not associated with reduced CoQ10 levels but with increased intrinsic mitochondrial respiratory capacity.", "population_specificity": "Patients on simvastatin therapy (64 total, 25 with myalgia, 39 without symptoms) and 20 untreated high-cholesterol controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:14.759216+00:00"}
{"study_id": 62877, "supplement_id": 1036, "safety_score": "85", "efficacy_score": 40, "quality_score": 75, "study_goal": "The researchers aimed to determine if 8 weeks of CoQ10 supplementation could improve glucose homeostasis in simvastatin-treated subjects.", "results_summary": "CoQ10 supplementation did not change muscle GLUT4 content, insulin sensitivity, or secretory capacity, but hepatic insulin sensitivity may have improved. No significant changes were observed in fasting plasma insulin, glucose, or glucose tolerance.", "population_specificity": "Thirty-five men and women on a minimum daily dose of 40 mg simvastatin.", "effective_dosage": "2 \u00d7 200 mg/day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:15.241957+00:00"}
{"study_id": 62878, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of CoQ10 supplementation on glycemic control and lipid profile markers in diabetic hemodialysis patients.", "results_summary": "CoQ10 supplementation significantly improved markers of insulin metabolism but did not affect fasting glucose, HbA1c, or most lipid profiles. A trend toward reduced triglycerides and VLDL-cholesterol was observed, though not statistically significant.", "population_specificity": "Diabetic hemodialysis patients (n=60).", "effective_dosage": "120 mg/day.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:18.655603+00:00"}
{"study_id": 62879, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effects of CoQ10 and/or vitamin E on glucose homeostasis parameters and reproductive hormones in women with PCOS.", "results_summary": "CoQ10 alone or combined with vitamin E significantly improved fasting blood sugar, insulin resistance (HOMA-IR), and reduced total testosterone levels. Combined supplementation also increased sex hormone-binding globulin (SHBG) levels.", "population_specificity": "86 women with polycystic ovary syndrome (PCOS).", "effective_dosage": "Not specified in the abstract.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:19.605024+00:00"}
{"study_id": 62881, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether dietary supplementation with CoQ10 and Creatine improves functional performance, body composition, and dyspnea perception in COPD patients.", "results_summary": "The study found that CoQ10 and Creatine supplementation improved functional performance, body composition, and dyspnea perception in COPD patients, with systemic increases in anti-inflammatory metabolites suggesting a biological mechanism for these benefits.", "population_specificity": "108 patients with COPD from 9 Italian hospitals.", "effective_dosage": "Not specified in the abstract.", "study_duration": "2 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:21.857143+00:00"}
{"study_id": 62880, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the role of Coenzyme Q10 in mitochondrial function, particularly its potential to boost electron transfer system function during and after critical illness.", "results_summary": "The study suggests Coenzyme Q10 may help improve mitochondrial function by enhancing the electron transfer system, but no specific clinical outcomes or efficacy data are provided. The abstract highlights the lack of studies guiding optimal micronutrient requirements for mitochondrial recovery in critical illness.", "population_specificity": "Patients during or after critical illness (general review, not specific to a particular group).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:21.927583+00:00"}
{"study_id": 62883, "supplement_id": 1036, "safety_score": "100", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to determine whether Coenzyme Q10 administration improves insulin resistance in patients with prediabetes.", "results_summary": "Coenzyme Q10 significantly reduced HOMA-IR values (P < .001) and correlated with free oxygen radical concentrations, but did not affect fasting blood glucose, insulin, or glycated hemoglobin levels. No adverse events were reported.", "population_specificity": "Adults aged \u226520 years with impaired glucose tolerance (prediabetes).", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:22.336697+00:00"}
{"study_id": 62884, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review available clinical data on the effects of nutraceuticals, including Coenzyme Q10, on NAFLD and related parameters.", "results_summary": "The abstract does not provide specific findings on Coenzyme Q10's effects, only mentioning it as one of the nutraceuticals analyzed.", "population_specificity": "Patients with NAFLD, particularly those with diabetes or obesity.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:22.611110+00:00"}
{"study_id": 62882, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine if acute influenza infection is associated with CoQ10 depletion compared to healthy controls and to assess correlations between CoQ10 levels, illness severity, and inflammatory biomarkers.", "results_summary": "Patients with acute influenza had significantly lower CoQ10 levels than controls, with weak correlations observed between CoQ10 levels and certain inflammatory biomarkers (IL-2, TNF-alpha, VEGF), but no correlation with illness severity.", "population_specificity": "Patients with acute influenza and healthy controls from a single urban tertiary care center.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:23.909715+00:00"}
{"study_id": 62885, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to review emerging pharmacotherapies, including Coenzyme Q10, for their potential in delaying disease onset and mitigating Parkinson's disease progression.", "results_summary": "The abstract mentions Coenzyme Q10 as one of the antioxidants under investigation for Parkinson's disease, but specific results regarding its efficacy are not detailed. Emerging treatments, including Coenzyme Q10, show promise but require further research.", "population_specificity": "Patients with Parkinson's disease (advanced stages mentioned for some interventions).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:26.947438+00:00"}
{"study_id": 62886, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of Coenzyme Q10 supplementation in treating patients with cardiovascular diseases, particularly congestive heart failure.", "results_summary": "The study found that CoQ10 may be beneficial as an adjunctive therapy for congestive heart failure, improving cardiac output, cardiac index, and functional classification, especially in patients intolerant to mainstream treatments. However, no meta-analyses were conducted due to study heterogeneity.", "population_specificity": "Patients with cardiovascular diseases, specifically congestive heart failure.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:27.556948+00:00"}
{"study_id": 62887, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether oral antioxidant therapies, including Coenzyme Q10, could prevent or treat preeclampsia in pregnant women.", "results_summary": "The study found that Coenzyme Q10, along with other antioxidants, showed no beneficial effects on the prevention of preeclampsia.", "population_specificity": "Pregnant women", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:28.790550+00:00"}
{"study_id": 62888, "supplement_id": 1036, "safety_score": "90", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to determine whether adjuvant CoQ10 improves symptoms of depression in patients with bipolar disorder compared to placebo, focusing on its antioxidant and anti-inflammatory properties.", "results_summary": "Adjuvant CoQ10 improved symptoms of depression after 8 weeks compared to placebo, with more responders in the CoQ10 group. CoQ10 was well tolerated with minimal adverse effects.", "population_specificity": "69 patients with bipolar disorder experiencing a current depressive episode.", "effective_dosage": "200 mg/d", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:29.744988+00:00"}
{"study_id": 62889, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the rationale and efficacy of Coenzyme Q10 supplementation for mitigating statin-associated muscle symptoms (SAMS).", "results_summary": "The study found mixed results regarding CoQ10's efficacy in alleviating SAMS, with some studies suggesting benefits while others showed no significant effects. The abstract highlights the equivocal nature of the data on CoQ10 supplementation for this purpose.", "population_specificity": "Patients experiencing statin-associated muscle symptoms (SAMS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:30.613111+00:00"}
{"study_id": 62891, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to describe the pharmacology, pathophysiology, and clinical spectrum of CTD leukoencephalopathy and propose diagnostic criteria for a Coenzyme Q10 therapeutic trial.", "results_summary": "The abstract does not provide specific results regarding Coenzyme Q10's effects, only mentioning it as a potential therapeutic trial for CTD leukoencephalopathy.", "population_specificity": "Individuals with heroin abuse, specifically those using the \"chasing the dragon\" (CTD) method.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:32.306736+00:00"}
{"study_id": 62890, "supplement_id": 1036, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Coenzyme Q10, combined with red yeast rice and added to diet and lifestyle management, was more effective than diet alone in improving blood pressure, lipid, and glucose profiles in patients with metabolic syndrome.", "results_summary": "The study found that Coenzyme Q10 supplementation significantly improved systolic and diastolic blood pressure, total cholesterol, LDL cholesterol, triglycerides, and glucose levels compared to diet alone, with no significant changes in HDL cholesterol. The treatment was well-tolerated and safe.", "population_specificity": "104 subjects with metabolic syndrome (mean age 57.4 \u00b1 8.8 years, 51% males) without a history of cardiovascular diseases.", "effective_dosage": "Once-daily oral formulation (specific dosage not detailed).", "study_duration": "2 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:32.490936+00:00"}
{"study_id": 62892, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential neuroprotective effects of lipophilic antioxidants, including Coenzyme Q10, in neurodegenerative diseases.", "results_summary": "The study found that Coenzyme Q10 demonstrated neuroprotection in cellular and animal models, but clear-cut clinical evidence for beneficial effects in neurodegenerative diseases is lacking. Future studies may optimize factors like dosage and delivery route for better outcomes.", "population_specificity": "Not specified (focused on cellular and animal models, with implications for neurodegenerative diseases).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:35.088731+00:00"}
{"study_id": 62893, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to examine the effects of liquid ubiquinol supplementation on glucose, lipid levels, and antioxidant capacity in type 2 diabetes patients.", "results_summary": "The study found that liquid ubiquinol supplementation significantly reduced HbA1c levels, increased antioxidant enzyme activities (catalase and glutathione peroxidase), and maintained HDL-cholesterol levels, while lipid profiles remained unchanged.", "population_specificity": "Type 2 diabetes patients (n=50, randomized into placebo and ubiquinol groups).", "effective_dosage": "100 mg/d of liquid ubiquinol.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:35.850818+00:00"}
{"study_id": 62895, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to discuss diagnostic investigations, including Coenzyme Q10 deficiency, in the context of treatable metabolic ataxias.", "results_summary": "The abstract does not provide specific results regarding Coenzyme Q10's effects but highlights its relevance in diagnosing metabolic ataxias.", "population_specificity": "Patients with subacute to chronic cerebellar ataxias.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:36.705939+00:00"}
{"study_id": 62894, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effects of CoQ10 supplementation on serum markers related to insulin resistance and oxidative stress in women with type 2 diabetes mellitus (T2DM).", "results_summary": "CoQ10 supplementation significantly increased adiponectin and the A/L ratio while decreasing leptin, MDA, and 8-isoprostane levels, suggesting potential benefits for improving insulin resistance and reducing oxidative stress in T2DM patients.", "population_specificity": "68 women with type 2 diabetes mellitus (T2DM).", "effective_dosage": "100 mg CoQ10 per day.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:37.603602+00:00"}
{"study_id": 62897, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the symptomatic relief provided by Coenzyme Q10 in a patient with LGMD2B.", "results_summary": "Coenzyme Q10 was part of symptomatic treatments that led to obvious relief of symptoms and a decrease in serum CK levels in the patient. The study suggests potential benefits but lacks detailed efficacy analysis.", "population_specificity": "A 25-year-old woman diagnosed with LGMD2B (Limb-girdle muscular dystrophy type 2B).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:39.228045+00:00"}
{"study_id": 62900, "supplement_id": 1036, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Coenzyme Q10 (CoQ10) combined with trimetazidine (TMZ) could prevent contrast-induced nephropathy (CIN) in patients with renal dysfunction undergoing elective cardiac catheterization.", "results_summary": "CoQ10 plus TMZ significantly reduced the incidence of CIN compared to the control group (6.67% vs. 21.3%) and demonstrated renal protective effects by reducing oxidative stress and tubular injuries in an animal model. No side effects were observed with CoQ10 and TMZ administration.", "population_specificity": "Coronary artery disease patients with renal insufficiency scheduled for coronary angiography.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Effects were measured at 48 and 72 hours post-procedure.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:42.117647+00:00"}
{"study_id": 62898, "supplement_id": 1036, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the lipid-lowering effects and safety of a dietary supplement containing Coenzyme Q10 (Argicolina) with another commercially available product (Normolip 5) in patients with hypercholesterolemia.", "results_summary": "The study found that both supplements significantly reduced LDL-C and total cholesterol, with Argicolina also showing a notable reduction in triglycerides. No serious adverse events were reported, indicating good safety profiles for both supplements.", "population_specificity": "20 Caucasian outpatients aged 18-75 years with serum LDL-C between 130 and 180 mg/dL.", "effective_dosage": "Monacolin K 10 mg (both supplements), Coenzyme Q10 dosage not specified.", "study_duration": "8 weeks per treatment, separated by a 4-week wash-out period.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:42.738926+00:00"}
{"study_id": 62901, "supplement_id": 1036, "safety_score": "85", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of Coenzyme Q10 in managing coronary heart disease, particularly its effects on statin-associated muscle symptoms (SAMS) and heart failure.", "results_summary": "CoQ10 appears safe and showed promise in improving functional capacity and reducing cardiovascular events in heart failure patients, but its effects on specific cardiovascular risk factors like blood pressure and glycemic control were less impressive. Current evidence does not support routine use in coronary heart disease.", "population_specificity": "Patients with coronary heart disease, particularly those with statin-associated muscle symptoms (SAMS) and heart failure.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:43.294603+00:00"}
{"study_id": 62902, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the role of empiric treatment with coenzyme Q10 in genetic abnormalities leading to coenzyme Q deficiency, particularly in pediatric patients with ataxia.", "results_summary": "The abstract suggests empiric treatment with coenzyme Q10 for genetic abnormalities causing coenzyme Q deficiency, implying potential efficacy, but no specific outcomes or data are provided.", "population_specificity": "Pediatric patients presenting with ataxia, particularly those with genetic disorders leading to coenzyme Q deficiency.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:43.643199+00:00"}
{"study_id": 62904, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to explore the potential of Coenzyme Q10 as a promising biological treatment for Neurotrophic Keratopathy (NK).", "results_summary": "The abstract suggests that Coenzyme Q10, along with other biologicals, offers promise for treating NK, though specific efficacy data or outcomes are not detailed.", "population_specificity": "Patients with Neurotrophic Keratopathy (NK).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:44.821263+00:00"}
{"study_id": 62903, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate Coenzyme Q10 as a potential therapeutic agent for improving myocardial energetics and clinical heart failure status.", "results_summary": "Coenzyme Q10 was identified as one of the promising therapies under investigation for improving heart failure symptoms by targeting cellular and mitochondrial metabolism, with potential benefits over current guideline-based therapies.", "population_specificity": "Patients with heart failure (specific details not provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:45.065851+00:00"}
{"study_id": 62906, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to analyze the role of Coenzyme Q10 in various cardiometabolic disorders, including hypertension, ischemic heart disease, heart failure, and metabolic conditions like diabetes and obesity.", "results_summary": "The study suggests that CoQ10 supplementation may be beneficial for a range of cardiometabolic disorders, with growing evidence supporting its role in both chronic and acute conditions. However, the abstract does not provide specific outcome data or statistical significance.", "population_specificity": "Patients with cardiometabolic disorders (e.g., hypertension, heart failure, diabetes, obesity).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:47.874821+00:00"}
{"study_id": 62909, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the efficacy and safety of Coenzyme Q10 as a nutraceutical for migraine prevention in children and adolescents.", "results_summary": "The abstract does not provide specific findings for Coenzyme Q10, but notes that overall evidence for nutraceuticals in pediatric migraine is limited and inconclusive due to low-quality studies.", "population_specificity": "Children and adolescents with migraine.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:50.488669+00:00"}
{"study_id": 62908, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of CoQ10 supplementation on lipid profiles in patients with metabolic disorders.", "results_summary": "CoQ10 supplementation significantly reduced serum triglycerides levels but did not show statistically significant effects on total cholesterol, LDL-cholesterol, or HDL-cholesterol levels. The study suggests CoQ10 may help improve lipid profiles in metabolic disorder patients.", "population_specificity": "Patients with metabolic disorders (514 patients and 525 controls across 21 trials).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:51.112205+00:00"}
{"study_id": 62896, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of topical Coenzyme Q10 (CQ10) and vitamin E (Coqun drop) on oxidative stress markers (superoxide dismutase and malondialdehyde) in patients with pseudo-exfoliative glaucoma.", "results_summary": "The study found significantly lower superoxide dismutase levels in pseudo-exfoliative glaucoma patients treated with Coqun compared to untreated patients, suggesting a potential oxidative stress-modulating effect. No significant changes were observed in malondialdehyde levels after 1 month of treatment.", "population_specificity": "64 eyes of 64 patients with pseudo-exfoliative glaucoma or pseudo-exfoliation syndrome undergoing cataract surgery.", "effective_dosage": "100 mg CQ10 and 500 mg Vitamin E TPGS (Coqun drop) twice daily.", "study_duration": "1 month preoperatively.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:51.860423+00:00"}
{"study_id": 62907, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether supplementation with selenium and Coenzyme Q10 reduced cardiovascular mortality over a 12-year follow-up period in healthy elderly individuals and specific subgroups.", "results_summary": "The study found significantly reduced cardiovascular mortality (28.1% vs. 38.7%) in the supplemented group, with sustained benefits observed even 12 years post-intervention, particularly in subgroups with diabetes, hypertension, ischemic heart disease, or impaired functional capacity.", "population_specificity": "Healthy elderly individuals (n=443) from a rural Swedish municipality, including subgroups with diabetes, hypertension, ischemic heart disease, or impaired cardiac function.", "effective_dosage": "Not specified in the abstract.", "study_duration": "4 years of supplementation, followed by 12 years of follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:52.471971+00:00"}
{"study_id": 62911, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether Coenzyme Q10 (CoQ10) pretreatment improves ovarian response, embryo quality, and IVF-ICSI outcomes in young women with poor ovarian reserve.", "results_summary": "CoQ10 pretreatment significantly improved ovarian response (higher oocyte retrieval, fertilization rates, and high-quality embryos), reduced gonadotrophin requirements, and decreased embryo transfer cancellations. Clinical pregnancy and live birth rates showed a non-significant trend toward improvement.", "population_specificity": "Young women (<35 years) with poor ovarian reserve (POSEIDON classification group 3).", "effective_dosage": "Not specified in the abstract.", "study_duration": "60 days preceding IVF-ICSI cycle.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:52.795385+00:00"}
{"study_id": 62912, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the independent and combined effects of CoQ10 supplementation on neutrophil leukotrienes, 5-HETE, SPM, and plasma MPO in patients with chronic kidney disease (CKD).", "results_summary": "The study found that CoQ10 supplementation (200 mg daily) did not significantly increase neutrophil LTB or affect other measured inflammatory markers, unlike n-3 fatty acids, which showed significant effects.", "population_specificity": "Patients with chronic kidney disease (CKD)", "effective_dosage": "200 mg daily", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:53.017075+00:00"}
{"study_id": 62913, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to evaluate the effects of a comprehensive nutritional and dietary intervention, including Coenzyme Q10, on nonverbal intellectual ability in individuals with autism spectrum disorder (ASD).", "results_summary": "The study found a significant improvement in nonverbal intellectual ability in the treatment group compared to the non-treatment group, but the specific contribution of Coenzyme Q10 was not isolated or discussed.", "population_specificity": "67 children and adults with autism spectrum disorder (ASD) ages 3-58 years and 50 non-sibling neurotypical controls of similar age and gender.", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:54.569624+00:00"}
{"study_id": 62914, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy and tolerability of an investigational multivitamin regimen versus a standard regimen in maintaining therapeutic levels of various vitamins and minerals, including Coenzyme Q10, in patients undergoing Roux-en-Y gastric bypass.", "results_summary": "The study measured plasma levels of Coenzyme Q10 at 3 months postoperatively but did not report specific findings or statistical significance regarding its efficacy or changes in levels.", "population_specificity": "Patients aged 18-65 undergoing Roux-en-Y gastric bypass.", "effective_dosage": "Not specified", "study_duration": "6 months (Coenzyme Q10 measured at 3 months)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:57.717843+00:00"}
{"study_id": 62915, "supplement_id": 1036, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to investigate the effect of CoQ10 on cardiovascular disease (CVD) risk factors in dyslipidemic patients not taking hypoglycemic or hypolipidemic drugs.", "results_summary": "CoQ10 supplementation significantly improved multiple CVD risk factors, including lowering blood pressure, triglycerides, LDL cholesterol, and insulin resistance while increasing antioxidant capacity and ApoA-I levels over 24 weeks.", "population_specificity": "Dyslipidemic patients not on hypoglycemic or hypolipidemic drugs.", "effective_dosage": "120 mg daily", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:58.347162+00:00"}
{"study_id": 62916, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 30, "study_goal": "The researchers aimed to evaluate the effects of Coenzyme Q10 supplementation in children with proteinuria renal disease caused by ADCK4 mutation.", "results_summary": "One patient showed reduced proteinuria after Coenzyme Q10 therapy, while the other did not improve, indicating mixed efficacy. The study suggests early genetic screening for ADCK4 mutations could help guide treatment decisions.", "population_specificity": "Children with proteinuria renal disease and ADCK4 mutation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:58.939911+00:00"}
{"study_id": 62917, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine the effects of Coenzyme Q10 supplementation on oxidative stress and metabolic parameters in women with Type 2 diabetes mellitus.", "results_summary": "The study found that Coenzyme Q10 supplementation significantly improved fasting blood sugar, insulin resistance, ferritin, total cholesterol, LDL-C, and HDL-C levels, with a marginal decrease in triglycerides.", "population_specificity": "Eighty women with Type 2 diabetes mellitus.", "effective_dosage": "100 mg/day", "study_duration": "Not specified in the abstract", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:59.805542+00:00"}
{"study_id": 62921, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 50, "study_goal": "The researchers aimed to determine whether Coenzyme Q10, in combination with other treatments, could improve symptoms in a patient with pulmonary hypertension complicated by mitochondrial disease.", "results_summary": "The patient's condition improved after treatment with Coenzyme Q10 alongside vitamin E, vitamin B2, and ATP, suggesting potential efficacy in managing symptoms of mitochondrial disease-associated pulmonary hypertension.", "population_specificity": "A 15-year-old boy with pulmonary hypertension and confirmed mitochondrial disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:01.202187+00:00"}
{"study_id": 62919, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether polymorphisms in the COQ2 gene, involved in CoQ10 biosynthesis, influence susceptibility to statin-associated muscle symptoms (SAMS).", "results_summary": "The study found no significant association between COQ2 gene polymorphisms (rs6535454 and rs4693075) and SAMS, suggesting that the CoQ10 pathway may not be critical for SAMS development. Haplotype distributions also showed no significant differences between groups.", "population_specificity": "Czech adult patients with SAMS (n=278), statin-treated patients without SAMS (n=293), and population controls (n=561).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:01.398951+00:00"}
{"study_id": 62920, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effect of selenium and coenzyme Q10 supplementation on biomarkers of fibrogenic activity in elderly individuals to understand potential mechanisms behind improved cardiac function.", "results_summary": "The study found that supplementation significantly decreased concentrations of most fibrogenic biomarkers (except ST2) compared to placebo, suggesting reduced fibrogenic activity, which may explain the observed improvements in cardiac function.", "population_specificity": "Healthy elderly persons (221 in the intervention group, 222 in the placebo group).", "effective_dosage": "Not specified in the abstract.", "study_duration": "4 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:02.214550+00:00"}
{"study_id": 62922, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether the combination of Coenzyme Q10 and creatine with physical exercise could serve as a pleiotropic approach to prevent or treat sarcopenia by addressing oxidative stress-related muscle impairment.", "results_summary": "The abstract notes contradictory results regarding the effects of antioxidants, including Coenzyme Q10, on sarcopenia, suggesting that not all antioxidants may effectively counteract the complex mechanisms of muscle decline. The combination of Coenzyme Q10 and creatine with exercise is proposed as a potential strategy, but definitive conclusions are not provided.", "population_specificity": "The abstract does not specify a particular population but implies relevance to aging individuals at risk of sarcopenia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:03.543163+00:00"}
{"study_id": 62923, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to review the potential of antioxidant therapy, including Coenzyme Q10, in treating cerebellar ataxias by examining existing literature and new perspectives.", "results_summary": "The study found that while antioxidants like Coenzyme Q10 show promise for cerebellar ataxias, conclusive evidence on their efficacy is still lacking, and more research is needed to identify effective treatment strategies.", "population_specificity": "Patients with hereditary cerebellar ataxias.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:05.291558+00:00"}
{"study_id": 62924, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of CoQ10 supplementation on glucose metabolism, lipid profiles, inflammation, and oxidative stress in subjects with diabetic nephropathy.", "results_summary": "CoQ10 supplementation significantly improved glucose metabolism (reduced insulin levels, insulin resistance, HbA1c) and oxidative stress markers (MDA, AGEs), but had no significant effect on fasting plasma glucose, lipid profiles, or MMP-2 levels.", "population_specificity": "50 subjects with diabetic nephropathy.", "effective_dosage": "100 mg/day", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:06.195238+00:00"}
{"study_id": 62925, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to critically evaluate the published data on the efficacy of CoQ10 supplements in preventing and treating statin-associated muscle symptoms (SAMS).", "results_summary": "The study found mixed results regarding CoQ10's efficacy, with some studies showing benefits in reducing SAMS incidence and severity, while others found no significant effects. Methodological and pharmacological issues complicate the interpretation of these findings.", "population_specificity": "Adults experiencing statin-associated muscle symptoms (SAMS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:06.658960+00:00"}
{"study_id": 62926, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to review the utility of Coenzyme Q10 as an oocyte quality enhancer in poor ovarian responders (POR).", "results_summary": "The abstract mentions CoQ10 as one of several oocyte quality enhancers reviewed, but no specific findings or data on its effectiveness are provided. The conclusion states there is no convincing data to determine the ideal protocol for ovarian stimulation in POR.", "population_specificity": "Poor ovarian responders (POR) as defined by the Bologna criteria.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:07.447670+00:00"}
{"study_id": 62929, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of Coenzyme Q10 in retinal diseases, focusing on its antioxidant properties and therapeutic potential for conditions like age-related macular degeneration and glaucoma.", "results_summary": "CoQ10 was found to improve visual function in age-related macular degeneration, protect ganglion cells in glaucoma models, and show potential for treating diabetic retinopathy and retinitis pigmentosa by mitigating oxidative stress.", "population_specificity": "Patients with retinal diseases (age-related macular degeneration, glaucoma, diabetic retinopathy, retinitis pigmentosa) and aging individuals.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:10.276928+00:00"}
{"study_id": 62927, "supplement_id": 1036, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy and tolerability of low-dose statin therapy versus combined therapy with low-dose statin plus a nutraceutical containing Coenzyme Q10 in high-risk patients with coronary artery disease and statin intolerance.", "results_summary": "The combination therapy including Coenzyme Q10 significantly reduced LDL-C and total cholesterol, with 70% of patients achieving the therapeutic target (LDL-C <70 mg/dl). Dropouts due to myalgia were equal in both groups, suggesting no additional safety concerns from the nutraceutical.", "population_specificity": "High-risk patients with coronary artery disease, prior percutaneous coronary intervention, and high-dose statin intolerance.", "effective_dosage": "Not specified (part of Armolipid Plus combination).", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:10.607856+00:00"}
{"study_id": 62928, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy and safety of a collyrium containing crosslinked hyaluronic acid (XLHA) with Coenzyme Q10 (CoQ10) compared to hyaluronic acid (HA) alone in treating mild to moderate dry eye disease (DED).", "results_summary": "The XLHA + CoQ10 treatment showed significantly greater improvements in OSDI scores, corneal staining, meibomian gland function, and epithelial cell reflectivity compared to HA alone. No significant differences were found in corneal aesthesiometry, TBUT, visual acuity, IOP, or fundus examination.", "population_specificity": "40 patients with mild to moderate dry eye disease.", "effective_dosage": "Eyedrops administered 4 times daily (specific CoQ10 concentration not provided).", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:11.278429+00:00"}
{"study_id": 62930, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to re-evaluate the efficacy of Coenzyme Q10 in reducing mortality and improving cardiac function in patients with heart failure.", "results_summary": "Coenzyme Q10 reduced mortality and improved exercise capacity compared to placebo, but no significant differences were observed in left heart ejection fraction or NYHA classification.", "population_specificity": "Patients with cardiac failure (2149 participants across 14 RCTs).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:11.367600+00:00"}
{"study_id": 62931, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were reviewing therapeutic approaches for Friedreich ataxia, including mitochondrial function improvement and frataxin expression enhancement, but did not specifically focus on Coenzyme Q10.", "results_summary": "The abstract does not provide specific findings related to Coenzyme Q10, as it broadly discusses therapeutic strategies for Friedreich ataxia without detailing Coenzyme Q10's role or effects.", "population_specificity": "Patients with Friedreich ataxia (FRDA).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:14.424459+00:00"}
{"study_id": 62933, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to investigate the short-term effects of in vivo ubiquinol (reduced Coenzyme Q10) on oxidative perturbation and mitochondrial dynamics in patients with antiphospholipid syndrome (APS).", "results_summary": "The study found that Coenzyme Q10 treatment could prevent oxidative disturbance linked to mitochondrial dysfunction in APS patients, suggesting potential benefits for their prothrombotic status. However, the abstract does not provide detailed quantitative results.", "population_specificity": "Thirty-six patients with antiphospholipid syndrome (APS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:14.924945+00:00"}
{"study_id": 62935, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to review the potential of Coenzyme Q10 and idebenone to rescue increased mitophagy in mitochondrial disease by improving mitochondrial function.", "results_summary": "The study suggests that Coenzyme Q10 may benefit mitochondrial function and mitigate excessive mitophagy in mitochondrial diseases, though specific efficacy data are not detailed. The abstract implies a therapeutic potential but lacks concrete results.", "population_specificity": "Patients with mitochondrial diseases (no specific subtype or demographic details provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:14.996476+00:00"}
{"study_id": 62932, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to analyze changes in oxidative stress markers, including Coenzyme Q10, in patients with advanced critical limb ischemia after bone marrow-derived mononuclear cell therapy.", "results_summary": "Coenzyme Q10 concentration significantly increased from 468 \u00b1 182 to 598 \u00b1 283 \u03bcg/L (p = 0.02) at 6 months follow-up in patients who responded to therapy, indicating improved antioxidant status.", "population_specificity": "50 patients (64 \u00b1 11 years, 44 males, 6 females) with advanced critical limb ischemia (Rutherford category 5 or 6) not eligible for revascularization.", "effective_dosage": "Not specified (Coenzyme Q10 was measured as an outcome, not administered).", "study_duration": "6 months follow-up after BM-MNC delivery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:16.139427+00:00"}
{"study_id": 62936, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to examine the effects of selenium and coenzyme Q10 supplementation on IGF-1 and IGFBP-1 levels in elderly individuals, as part of understanding the mechanistic effects behind reduced cardiovascular mortality.", "results_summary": "Supplementation with selenium and coenzyme Q10 significantly increased IGF-1 levels, IGF-1 SD scores, and IGFBP-1 concentrations compared to placebo, suggesting a positive impact on these biomarkers. The results indicate a potential mechanistic link to improved cardiovascular outcomes.", "population_specificity": "215 elderly individuals", "effective_dosage": "Not specified", "study_duration": "4 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:18.536901+00:00"}
{"study_id": 62938, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to highlight the role of Coenzyme Q10 biosynthesis defects as a treatable form of mitochondrial cytopathies, particularly in renal involvement.", "results_summary": "The study identified Coenzyme Q10 biosynthesis defects as one of the few treatable forms of mitochondrial cytopathies, emphasizing its potential therapeutic role in renal manifestations of these diseases.", "population_specificity": "Patients with mitochondrial cytopathies, including those with renal involvement such as tubular defects or glomerular diseases.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:19.173697+00:00"}
{"study_id": 62939, "supplement_id": 1036, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to assess the effect of combining Coenzyme Q10 with statins and omega-3 fatty acids on atherogenesis-related parameters and statin side effects.", "results_summary": "Coenzyme Q10 significantly reduced systolic blood pressure, total cholesterol, LDL, hsCRP, IL-6, and SOD levels compared to the statin+omega-3 group, and also reduced statin adverse effects.", "population_specificity": "105 subjects with combined dyslipidemia and elevated TAG levels.", "effective_dosage": "200 mg/day", "study_duration": "3 months (\u00b11 week)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:19.262091+00:00"}
{"study_id": 62937, "supplement_id": 1036, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy and safety of a food supplement containing Coenzyme Q10, red yeast rice, and berberine in lowering LDL-C and TC levels in patients with mild-to-moderate hypercholesterolemia.", "results_summary": "The supplement significantly reduced LDL-C and TC levels compared to placebo, with a 26.3% reduction in LDL-C. Adverse events were mild, except for one severe case unrelated to the supplement.", "population_specificity": "Patients with mild-to-moderate hypercholesterolemia.", "effective_dosage": "Not specified.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:20.421681+00:00"}
{"study_id": 62940, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential efficacy and side effects of Coenzyme Q10 as a nutraceutical treatment for migraine prophylaxis.", "results_summary": "The abstract suggests that Coenzyme Q10 is among the nutraceuticals studied for migraine prevention, with a growing body of research supporting its use, though specific efficacy details are not provided.", "population_specificity": "Individuals with headache disorders, particularly migraine sufferers.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:21.806541+00:00"}
{"study_id": 62942, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential of Coenzyme Q10 as a safe and effective adjunct in the prevention and treatment of breast cancer and its comorbidities.", "results_summary": "The study found sparse but promising evidence supporting Coenzyme Q10's role in targeting breast cancer progression mechanisms, though some contradictory data indicated null effects. Further well-designed clinical studies are needed to clarify its efficacy.", "population_specificity": "Breast cancer patients and those at risk for breast cancer.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:22.339066+00:00"}
{"study_id": 62943, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the effects of selenium and Coenzyme Q10 supplementation on microRNA expression in elderly participants and explore potential mechanisms behind previously reported cardiovascular benefits.", "results_summary": "The study found significant differences in the expression of over 100 microRNAs, with up to 4-fold changes, between the supplementation and placebo groups, suggesting a potential mechanism for reduced cardiovascular mortality and inflammation.", "population_specificity": "Healthy elderly participants", "effective_dosage": "200 mg/day of Coenzyme Q10 capsules", "study_duration": "4 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:23.865164+00:00"}
{"study_id": 62946, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess the effects of CoQ10 supplementation on serum levels of inflammatory markers (IL-6, TNF-\u03b1, CRP) in people with metabolic diseases.", "results_summary": "CoQ10 supplementation significantly increased serum CoQ10 levels and reduced TNF-\u03b1, but showed no significant effect on CRP or IL-6. The study suggests CoQ10 may partly improve inflammatory states but calls for further investigation.", "population_specificity": "People with metabolic diseases (428 subjects across 9 trials).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:27.040051+00:00"}
{"study_id": 62944, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if CoQ10 affects blood glucose (BGL) and HbA1c (HL) levels based on existing randomized clinical trials.", "results_summary": "CoQ10 significantly reduced BGL, especially at lower doses (<200 mg/d) and shorter durations (<12 weeks), but had no effect on HL. Subgroup analysis suggested benefits in patients with BGL >6 mmol/L and certain ethnic groups, though meta-regression did not fully support these findings.", "population_specificity": "Patients with varying blood glucose levels, including those with and without high BGL.", "effective_dosage": "<200 mg/day", "study_duration": "Not longer than 12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:27.368295+00:00"}
{"study_id": 62945, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of CoQ10 supplementation on inflammatory mediators (CRP, IL-6, TNF-\u03b1) by analyzing randomized controlled trials.", "results_summary": "CoQ10 supplementation significantly reduced CRP, IL-6, and TNF-\u03b1 levels, with greater effects observed in individuals with higher baseline IL-6. However, results should be interpreted cautiously due to heterogeneity and limited studies.", "population_specificity": "Patients from 17 randomized controlled trials (specific population not detailed in abstract).", "effective_dosage": "Not specified in abstract.", "study_duration": "Not specified in abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:27.370602+00:00"}
{"study_id": 62949, "supplement_id": 1036, "safety_score": "85", "efficacy_score": 20, "quality_score": 90, "study_goal": "The researchers aimed to determine whether high-dose Coenzyme Q10 could slow functional decline in early-stage Huntington disease patients.", "results_summary": "The study found no statistically significant differences between CoQ and placebo for primary or secondary outcomes, concluding that CoQ does not justify use for slowing HD progression. CoQ was generally safe and well-tolerated.", "population_specificity": "Early-stage Huntington disease patients (n = 609) across 48 sites in the US, Canada, and Australia.", "effective_dosage": "2,400 mg/d", "study_duration": "60 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:30.441690+00:00"}
{"study_id": 62948, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to compare the short-term effects of a combined micronutrient supplement (including Coenzyme Q10) versus l-carnitine alone on sperm parameters in subfertile men.", "results_summary": "Both treatments improved sperm parameters, but the combined micronutrient group (including Coenzyme Q10) showed greater relative improvements in sperm density and progressive motility compared to l-carnitine alone.", "population_specificity": "Male subjects aged 20-60 with at least one year of subfertility and pathological semen analysis.", "effective_dosage": "15 mg Coenzyme Q10 once daily (as part of a combined formulation).", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:30.444175+00:00"}
{"study_id": 62941, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the influence of dietary supplements, including Coenzyme Q10, on multiple sclerosis (MS) progression.", "results_summary": "The abstract mentions Coenzyme Q10 as one of the dietary supplements used by MS patients, but no specific results or effects of Coenzyme Q10 are detailed.", "population_specificity": "Patients with multiple sclerosis (MS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:31.332127+00:00"}
{"study_id": 62950, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the effects of CoQ10 supplementation on glucose metabolism and lipid profiles in women with polycystic ovary syndrome (PCOS).", "results_summary": "CoQ10 supplementation significantly improved glucose metabolism (reduced fasting plasma glucose, insulin concentrations, insulin resistance, and B-cell function) and lipid profiles (lowered total- and LDL-cholesterol) compared to placebo after 12 weeks. Adjusting for baseline values did not alter most findings, except LDL-cholesterol became nonsignificant.", "population_specificity": "60 women diagnosed with PCOS.", "effective_dosage": "100 mg per day.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:32.612968+00:00"}
{"study_id": 62953, "supplement_id": 1036, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the efficacy of Coenzyme Q10 as an add-on prophylactic treatment for reducing migraine frequency and severity in adults.", "results_summary": "CoQ10 significantly reduced the number and severity of migraine attacks compared to the control group, with no observed side effects. The number needed to treat for a \u226550% reduction in attack frequency was 1.6.", "population_specificity": "Adults diagnosed with migraine headache based on International Headache Society criteria.", "effective_dosage": "100 mg daily", "study_duration": "Not specified in the abstract", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:34.697067+00:00"}
{"study_id": 62947, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of a proprietary nutraceutical formulation containing Coenzyme Q10, among other compounds, in reducing total and LDL cholesterol as part of cardiovascular prevention.", "results_summary": "The abstract suggests that the combination of red yeast rice, policosanol, berberine, folic acid, astaxanthin, and Coenzyme Q10 (Armolipid Plus) has been studied in RCTs for lipid-lowering effects, but specific results for Coenzyme Q10 alone are not detailed.", "population_specificity": "Individuals requiring lipid-lowering interventions, likely those with elevated cholesterol or cardiovascular risk (specifics not detailed in abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:34.790166+00:00"}
{"study_id": 62952, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Coenzyme Q10 supplementation (300 mg/day) could reduce oxidative stress and inflammation while increasing antioxidant enzyme activity in hepatocellular carcinoma (HCC) patients after surgery.", "results_summary": "Coenzyme Q10 supplementation significantly decreased oxidative stress and inflammatory markers (hs-CRP and IL-6) while increasing antioxidant enzyme activity and vitamin E levels in HCC patients post-surgery.", "population_specificity": "Patients diagnosed with primary hepatocellular carcinoma (HCC) after surgery (n=41).", "effective_dosage": "300 mg/day", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:35.074866+00:00"}
{"study_id": 62951, "supplement_id": 1036, "safety_score": "85", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy and safety of Coenzyme Q10 (CoQ10) for treating motor dysfunction in Parkinson's disease (PD) patients through a meta-analysis of randomized clinical trials.", "results_summary": "The meta-analysis found no significant difference in motor symptoms (UPDRS scores) between CoQ10 and placebo groups, indicating CoQ10 was not superior to placebo for PD treatment. However, CoQ10 was well tolerated and safe.", "population_specificity": "Patients with Parkinson's disease (899 participants across 8 studies).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:35.538644+00:00"}
{"study_id": 62954, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the role of Coenzyme Q10 as an adjunctive therapy for heart failure.", "results_summary": "The study suggests Coenzyme Q10 can be useful as adjunctive therapy for heart failure, though the abstract does not provide specific efficacy details.", "population_specificity": "Patients with heart failure (specifics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:37.264945+00:00"}
{"study_id": 62955, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of Coenzyme Q10 as a treatment for Parkinson's disease, specifically its impact on motor symptoms and disease modification.", "results_summary": "The study found that Coenzyme Q10, along with other tested treatments like pramipexole and creatine monohydrate, did not prove efficacious in clinical trials for Parkinson's disease. No significant positive outcomes were reported.", "population_specificity": "Patients with Parkinson's disease (specific demographics not detailed in the abstract).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:39.122405+00:00"}
{"study_id": 62956, "supplement_id": 1036, "safety_score": "85", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to assess the effects of pharmacological treatments, including Coenzyme Q10 and vitamin E, on neurological and cardiac outcomes in people with Friedreich ataxia.", "results_summary": "The study found no significant difference in neurological status between antioxidant-treated and placebo groups. A small decrease in left ventricular mass was observed in one study, but its clinical significance is unclear.", "population_specificity": "Individuals with genetically-confirmed Friedreich ataxia.", "effective_dosage": "High-dose versus low-dose Coenzyme Q10 and vitamin E (specific amounts not detailed in the abstract).", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:39.378620+00:00"}
{"study_id": 62957, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to compare the effectiveness of phosphocreatine versus a control treatment (including Coenzyme Q10) in leukemia patients with anthracycline-induced cardiotoxicity.", "results_summary": "The study found no significant differences in overall survival, mortality due to heart failure, echocardiographic cardiac function, or adverse events between the phosphocreatine and control groups (which included Coenzyme Q10). Limited data with a high risk of bias showed no clear benefit of the control treatment over phosphocreatine.", "population_specificity": "Childhood leukemia patients with anthracycline-induced cardiotoxicity.", "effective_dosage": "Not specified", "study_duration": "Two weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:40.968910+00:00"}
{"study_id": 62960, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to compare the bioavailability of a new liquid emulsion CoQ10 formulation versus a commercial solid powder and assess their effects on other antioxidants.", "results_summary": "The liquid emulsion showed a 489% increase in bioavailability over the solid form, with higher plasma CoQ10 levels after multiple doses (3.9-fold vs. 2.4-fold). No significant changes in other antioxidants were observed.", "population_specificity": "Six healthy individuals", "effective_dosage": "250 mg daily", "study_duration": "1 week", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:42.673284+00:00"}
{"study_id": 62961, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to analyze the state-of-the-art of nutritional deficiencies in heart failure, focusing on the physiological role and prognostic impact of micronutrient supplementation, including Coenzyme Q10.", "results_summary": "The abstract does not provide specific findings on Coenzyme Q10 but highlights that data on micronutrient supplementation efficacy in heart failure lack support from large randomized trials and have limited evidence regarding outcomes.", "population_specificity": "Patients with heart failure (HF).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:42.818214+00:00"}
{"study_id": 62959, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the potential of Coenzyme Q10 as part of a pharmaceutical strategy for treating steroid-induced bone infarction (SIBI).", "results_summary": "The abstract mentions Coenzyme Q10 as one of several pharmacologically active compounds used in treating SIBI, but it does not provide specific results regarding its effectiveness. It states that no pharmaceutical agent completely treats SIBI due to multiple contributing factors.", "population_specificity": "Patients with steroid-induced bone infarction (SIBI).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:43.180912+00:00"}
{"study_id": 62958, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to summarize the effect of Co-Q10 supplementation on diabetes biomarkers, specifically fasting blood glucose, fasting insulin, and HbA1c.", "results_summary": "Co-Q10 supplementation slightly but significantly reduced fasting blood glucose but had no significant effect on fasting insulin or HbA1c. The findings were inconsistent, with substantial heterogeneity initially observed, which was resolved after removing three studies.", "population_specificity": "Individuals studied in randomized controlled trials examining diabetes biomarkers (specific population details not provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:43.236631+00:00"}
{"study_id": 62964, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of Coenzyme Q10 supplementation on heart failure patients, focusing on its potential to improve cardiac function and clinical outcomes.", "results_summary": "The study found that CoQ10 supplementation improves impaired cardiac function and clinical course in heart failure patients, significantly reducing morbidity and mortality when added to guideline-recommended pharmacotherapy.", "population_specificity": "Patients with heart failure.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:46.479743+00:00"}
{"study_id": 62962, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether Coenzyme Q10 could be an effective treatment for patients with SRNS caused by mutations in genes related to CoQ10 biosynthesis (COQ2, COQ6, ADCK4, or PDSS2).", "results_summary": "The study identified that patients with mutations in CoQ10 biosynthesis genes may benefit from Coenzyme Q10 treatment, suggesting potential therapeutic efficacy for this specific genetic subgroup of SRNS patients.", "population_specificity": "Patients with steroid-resistant nephrotic syndrome (SRNS) caused by mutations in COQ2, COQ6, ADCK4, or PDSS2 genes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:46.480362+00:00"}
{"study_id": 62963, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to investigate the potential benefits of Coenzyme Q10 in improving corneal lesions in patients with Kearns-Sayre syndrome (KSS) and explore its possible role in Fuchs Endothelial Corneal Dystrophy (FECD).", "results_summary": "CoQ10 improved corneal disease in two children with KSS, showing microcystic changes and endothelial excrescences similar to FECD. The study suggests CoQ10 may benefit mitochondrial diseases due to its antioxidant properties and role in oxidative phosphorylation.", "population_specificity": "Two children with Kearns-Sayre syndrome (KSS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:47.832640+00:00"}
{"study_id": 62965, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether the cardiovascular mortality effects of combined selenium and Coenzyme Q10 supplementation depended on baseline selenium levels in elderly individuals.", "results_summary": "Supplementation with Coenzyme Q10 and selenium reduced cardiovascular mortality in participants with low baseline selenium levels (\u226485 \u03bcg/L), but no significant effect was observed in those with higher selenium levels (>85 \u03bcg/L). The greatest benefit was seen in the lowest selenium group, with a 12% absolute risk reduction.", "population_specificity": "Healthy elderly individuals from a Swedish municipality.", "effective_dosage": "200 mg Coenzyme Q10 daily, combined with 200 \u03bcg selenium (as selenized yeast).", "study_duration": "4 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:50.260742+00:00"}
{"study_id": 62966, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the clinical efficacy of a nutraceutical combination containing Coenzyme Q10 in improving lipid and glucose metabolism in adults with suboptimal LDL cholesterol.", "results_summary": "The study found that the nutraceutical combination significantly improved total cholesterol, LDL-C, non-HDL-C, liver transaminases, and hs-CRP levels compared to placebo, with no changes in other parameters.", "population_specificity": "30 adults with suboptimal LDL cholesterol in primary prevention of cardiovascular disease.", "effective_dosage": "Not specified", "study_duration": "6 weeks of treatment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:50.907192+00:00"}
{"study_id": 62967, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to explore the association of COQ2 variants and Coenzyme Q10 deficiency with multiple system atrophy (MSA) and its potential role in disease pathogenesis.", "results_summary": "The abstract reports evidence of Coenzyme Q10 deficiency in serum and brains of MSA patients, but the association of COQ2 variants with the disease remains debated, particularly in non-Asian populations. No definitive conclusions on therapeutic efficacy are provided.", "population_specificity": "Patients with atypical parkinsonism, specifically multiple system atrophy (MSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:51.090748+00:00"}
{"study_id": 62968, "supplement_id": 1036, "safety_score": "85", "efficacy_score": 40, "quality_score": 75, "study_goal": "The researchers aimed to determine whether pretreatment with Coenzyme Q10 could reduce periprocedural myocardial injury (PMI) following elective percutaneous coronary intervention (PCI).", "results_summary": "The study found no significant reduction in PMI biomarkers (CK-MB and troponin-I) with CoQ10 pretreatment, but it did observe a significant decrease in hs-CRP levels. No difference in major adverse cardiac effects (MACEs) was noted between groups after one month.", "population_specificity": "100 patients scheduled for elective PCI.", "effective_dosage": "300 mg loading dose 12 hours before the procedure.", "study_duration": "Single dose administered 12 hours pre-procedure.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:51.846557+00:00"}
{"study_id": 62969, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the lipid- and glucose-lowering effects of a nutraceutical combination (NComb) containing Coenzyme Q10 through a systematic review and meta-analysis of randomized controlled trials.", "results_summary": "The study found that NComb supplementation significantly improved plasma levels of total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, and glucose, with greater glucose-lowering effects observed in individuals with higher baseline glucose levels and longer supplementation durations.", "population_specificity": "Individuals with dyslipidemia and hyperglycemia (1670 subjects in the NComb arm for lipid analysis, 1014 subjects for glucose analysis).", "effective_dosage": "Not specified", "study_duration": "Varied across included trials (not specified in abstract)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:53.729455+00:00"}
{"study_id": 62970, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the importance of analytical methods for detecting and quantifying CoQ10 in clinical and pharmaceutical settings.", "results_summary": "The abstract highlights the significance of CoQ10 as a mitochondrial cofactor and antioxidant, emphasizing the need for early diagnosis and treatment of CoQ10 deficiency. It discusses the advantages and disadvantages of various analytical methods for CoQ10 detection but does not present specific efficacy or safety outcomes.", "population_specificity": "Not specified (general discussion of clinical and pharmaceutical applications).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:54.525571+00:00"}
{"study_id": 62971, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the biological roles, biosynthesis, and clinical implications of Coenzyme Q10 (CoQ10), particularly its deficiency and treatment efficacy.", "results_summary": "The study found that CoQ10 plays essential roles in mitochondrial function, including electron transport and antioxidant activity. Mutations in COQ genes cause clinically heterogeneous disorders, but oral CoQ10 supplementation is an effective treatment, though limited by bioavailability issues.", "population_specificity": "Patients with primary CoQ10 deficiency, ranging from newborns to adults in their seventh decade.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:54.825608+00:00"}
{"study_id": 62973, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effectiveness of a dual product regimen containing Coenzyme Q10 (ubiquinone) as part of an anti-aging moisturizer in improving facial skin conditions in women with mild to moderate hyperpigmentation and photodamage.", "results_summary": "The regimen, which included Coenzyme Q10, showed statistically significant improvements in clinical grading scores for all assessed parameters by weeks 8 and 12, with some improvements noted as early as week 4. The study did not isolate Coenzyme Q10's individual effects but reported overall positive outcomes for the combined regimen.", "population_specificity": "44 women with mild to moderate hyperpigmented and photodamaged facial skin.", "effective_dosage": "Not specified (Coenzyme Q10 was part of a moisturizer with 30% vitamin C, vitamin E, and other ingredients).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:58.441456+00:00"}
{"study_id": 62975, "supplement_id": 1036, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety, efficacy, and clinical benefits of Coenzyme Q10 supplementation in patients with heart failure (HF).", "results_summary": "The study found that CoQ10 supplementation reduced major adverse cardiovascular events in a contemporary HF population, with few reported side effects or drug interactions. The Q-SYMBIO trial provided evidence supporting its potential as a safe therapeutic option.", "population_specificity": "Patients with heart failure (both preserved and reduced ejection fraction).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "Few drug interactions mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:59.314073+00:00"}
{"study_id": 62974, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the therapeutic efficacy of Coenzyme Q10 (CQ10) and trimetazidine, individually and in combination, for treating acute viral myocarditis.", "results_summary": "CQ10 reduced inflammatory and oxidative stress biomarkers, but combination therapy with trimetazidine showed significantly greater improvements in left ventricular systolic function and troponin levels compared to either treatment alone.", "population_specificity": "Patients with acute viral myocarditis.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:59.368192+00:00"}
{"study_id": 62976, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Coenzyme Q10 (CoQ) could modify telomere length and reduce oxidative stress in patients with chronic kidney disease (CKD).", "results_summary": "The study found no effect of CoQ on telomere length in neutrophils or peripheral blood mononuclear cells (PBMCs). However, n-3 fatty acids (not CoQ) increased telomere length corrected for neutrophil count, possibly due to reduced oxidative stress.", "population_specificity": "85 patients with chronic kidney disease (CKD).", "effective_dosage": "200 mg daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:59.496055+00:00"}
{"study_id": 62977, "supplement_id": 1036, "safety_score": "80", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to determine whether Coenzyme Q10 effectively lowers blood pressure in individuals with primary hypertension.", "results_summary": "The meta-analysis of two RCTs found no significant reduction in systolic or diastolic blood pressure with Coenzyme Q10. The supplement was well-tolerated in one trial reporting adverse effects, but more high-quality trials are needed due to limited data.", "population_specificity": "Patients with primary hypertension.", "effective_dosage": "Not specified in the abstract.", "study_duration": "At least three weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:00.319930+00:00"}
{"study_id": 62978, "supplement_id": 1036, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the safety and efficacy of a combination supplement containing Coenzyme Q10 and other antioxidants in improving skin properties and preventing oxidative damage.", "results_summary": "The study found that the supplement improved skin elasticity, sebum production, and dermal markers without causing oxidative damage, though some redox parameters like NO and MDA increased moderately but remained within normal ranges.", "population_specificity": "41 volunteers (specific demographics not detailed).", "effective_dosage": "Not specified.", "study_duration": "2 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:01.168017+00:00"}
{"study_id": 62979, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 40, "study_goal": "The researchers aimed to investigate the role of Coenzyme Q10 in improving cerebellar ataxia induced by statin use.", "results_summary": "The study found that after statin withdrawal and treatment with Coenzyme Q10 in some patients, progressive improvement of gait ataxia was observed, suggesting a potential benefit of Coenzyme Q10 in addressing statin-induced cerebellar ataxia.", "population_specificity": "Elderly patients (mean age 67.5 years), predominantly male, with comorbidities including dyslipidemia, diabetes mellitus, hypertension, and myocardial revascularization.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:02.723726+00:00"}
{"study_id": 62980, "supplement_id": 1036, "safety_score": "80", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of CoQ10 supplementation on oxidative stress markers and exercise performance measures in hemodialysis patients.", "results_summary": "The study found no significant effect of CoQ10 supplementation on exercise performance measures (walking distance, VO2max) or oxidative stress markers compared to placebo. Serum CoQ10 levels increased with supplementation, but no differences in outcomes were observed between groups.", "population_specificity": "Maintenance hemodialysis patients", "effective_dosage": "200 mg/d", "study_duration": "Not specified (crossover study design)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:02.835098+00:00"}
{"study_id": 62981, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether Coenzyme Q10 supplementation reduces plasma lipoprotein(a) [Lp(a)] levels and its efficacy across different clinical settings.", "results_summary": "CoQ10 supplementation led to a slight but significant reduction in plasma Lp(a) levels, particularly in patients with higher baseline Lp(a) levels (\u226530 mg/dL). Other lipid indices remained unaffected.", "population_specificity": "409 subjects (206 in CoQ10 arm, 203 in control arm) from seven randomized controlled trials.", "effective_dosage": "Not specified (tested range of doses mentioned, but exact amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:07.159915+00:00"}
{"study_id": 62984, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to evaluate whether Coenzyme Q10 could serve as a potential cognitive enhancer for treating cognitive dysfunction in major depressive disorder (MDD).", "results_summary": "The abstract mentions Coenzyme Q10 as one of several novel agents that may be repurposed as cognitive enhancers for MDD treatment, but no specific results or data regarding its efficacy are provided.", "population_specificity": "Adults with major depressive disorder (MDD), particularly those experiencing cognitive dysfunction.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:07.234996+00:00"}
{"study_id": 62983, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of mitochondrial dysfunction, including CoQ10 biosynthesis defects, in renal diseases and its potential reversibility.", "results_summary": "The study found that CoQ10 biosynthesis defects are a significant cause of focal segmental glomerulosclerosis and that prompt diagnosis is crucial due to their potentially reversible nature. Mitochondrial dysfunction contributes to acute kidney injury, while mitochondrial biogenesis aids in renal function recovery.", "population_specificity": "Patients with mitochondrial cytopathies, including those with renal symptoms such as tubular defects, glomerular diseases, and cystic diseases.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:07.781670+00:00"}
{"study_id": 62982, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 50, "study_goal": "The researchers aimed to assess the risk of CoQ10 depletion in patients with PAD taking lipid-lowering medications and provide recommendations for monitoring and treatment.", "results_summary": "The study found that lipid-lowering medications may deplete CoQ10 levels, but the evidence was extrapolated from heterogeneous groups and ranged in quality from satisfactory to poor. Monitoring for deficiencies and potential supplementation was recommended.", "population_specificity": "Patients with peripheral arterial disease (PAD) and heterogeneous groups of patients/healthy adults (extrapolated data).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Lipid-lowering medications (risk of CoQ10 depletion)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:07.974353+00:00"}
{"study_id": 62986, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of oral coenzyme Q10 supplementation on pro-inflammatory factors and adiponectin in mildly hypertensive patients.", "results_summary": "Coenzyme Q10 supplementation significantly increased adiponectin levels and reduced IL6 and hs-CRP, but had no significant effect on TNF-\u03b1 and IL2.", "population_specificity": "Mildly hypertensive patients (n=60)", "effective_dosage": "100 mg per day", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:08.387669+00:00"}
{"study_id": 62985, "supplement_id": 1036, "safety_score": "90", "efficacy_score": 85, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effectiveness of Coenzyme Q10 eye drops as an adjuvant treatment for refractory corneal ulcers in challenging cases.", "results_summary": "All six cases of refractory corneal ulcers showed healing after adding CoQ10 eye drops, with complete healing observed between weeks 4 and 8 in four cases and within 1-2 weeks in two cases. No adverse events were reported.", "population_specificity": "Patients with refractory corneal ulcers, including neurotrophic corneal ulcers, postinfectious corneal ulcers, and Stevens-Johnson syndrome.", "effective_dosage": "Not specified", "study_duration": "1-8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:08.817452+00:00"}
{"study_id": 62987, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not explicitly state a research goal related to Coenzyme Q10.", "results_summary": "The abstract does not report any findings specific to Coenzyme Q10.", "population_specificity": "Not specified", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:08.986670+00:00"}
{"study_id": 62988, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize recent advancements in novel drug delivery systems for Coenzyme Q10 to overcome its solubility and bioavailability limitations.", "results_summary": "The study found that nanotechnology-based delivery systems (e.g., liposomes, nanoparticles) enhance CoQ10's therapeutic potential, making it more viable for medical, cosmetic, and nutraceutical applications. These innovations could revolutionize its role in therapy.", "population_specificity": "Not specified (broad therapeutic applications mentioned, including chronic heart failure, diabetes, and autoimmune diseases).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:11.647433+00:00"}
{"study_id": 62990, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effects of selenium and coenzyme Q10 on oxidative stress biomarkers (copeptin and adrenomedullin) and cardiovascular mortality in elderly individuals.", "results_summary": "Supplementation with selenium and coenzyme Q10 significantly reduced copeptin and MR-proADM levels compared to placebo and was associated with lower cardiovascular mortality over a 10-year follow-up period. The protective effects were observed regardless of initial biomarker levels.", "population_specificity": "437 elderly individuals", "effective_dosage": "Not specified", "study_duration": "4 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:15.165907+00:00"}
{"study_id": 62992, "supplement_id": 1036, "safety_score": "90", "efficacy_score": 20, "quality_score": 85, "study_goal": "To determine if coenzyme Q10 alleviates fatigue in polio survivors with late-onset sequelae of poliomyelitis.", "results_summary": "The study found no statistically significant reduction in fatigue between the coenzyme Q10 and placebo groups. Coenzyme Q10 was safe and well-tolerated.", "population_specificity": "Polio survivors from Australia with moderate to high fatigue attributed to late-onset sequelae of poliomyelitis, excluding those with fatigue-associated comorbidities.", "effective_dosage": "100 mg daily", "study_duration": "60 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:15.300881+00:00"}
{"study_id": 62991, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to compare and analyze various mitochondrion-permeable antioxidants, including Coenzyme Q10, to determine their effectiveness in treating ROS-related diseases.", "results_summary": "The abstract suggests Coenzyme Q10 is among the mitochondrion-permeable antioxidants considered, but it does not highlight specific findings about its efficacy compared to others. Astaxanthin is proposed as the best antioxidant for acute ROS-mediated diseases, implying Coenzyme Q10 may be less effective in such contexts.", "population_specificity": "Not specified (general ROS-related disease context).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:16.114476+00:00"}
{"study_id": 62993, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether long-term intervention with selenium and Coenzyme Q10 reduces cardiovascular mortality in elderly individuals and to assess subgroup differences.", "results_summary": "The study found significantly reduced cardiovascular mortality in the intervention group, with effects persisting for 10 years. Positive outcomes were observed across genders, those with ischemic heart disease, and different functional classes.", "population_specificity": "Healthy elderly individuals from a rural municipality in Sweden.", "effective_dosage": "Not specified", "study_duration": "4 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:16.248947+00:00"}
{"study_id": 62994, "supplement_id": 1036, "safety_score": "90", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy and tolerability of a nutraceutical combination containing Coenzyme Q10 compared to ezetimibe in improving lipid profiles in statin-intolerant patients with coronary heart disease.", "results_summary": "The study found that the nutraceutical combination, including Coenzyme Q10, was well tolerated and improved lipid profiles, with 72.5% of patients achieving their therapeutic target when combined with ezetimibe and 100% in the nutraceutical-only group after 1 year. No significant adverse effects were reported.", "population_specificity": "Dyslipidemic patients with ischemic heart disease treated with percutaneous coronary intervention (n=100).", "effective_dosage": "Not specified (part of a combination nutraceutical).", "study_duration": "3 months initial intervention, extended to 12 months for some patients.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:18.837155+00:00"}
{"study_id": 62995, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to synthesize evidence from RCTs on whether CoQ10 supplementation benefits patients with Parkinson's disease in terms of motor functions and quality of life.", "results_summary": "The study found no significant benefit of CoQ10 supplementation on total UPDRS scores, UPDRS I, II, III, or Schwab and England scores, indicating it does not slow functional decline or provide symptomatic improvement in Parkinson's disease.", "population_specificity": "Patients with Parkinson's disease (981 participants across 5 RCTs).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:18.895264+00:00"}
{"study_id": 62996, "supplement_id": 1036, "safety_score": "90", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety, tolerability, and efficacy of varying doses of CoQ10 in reducing oxidative stress biomarkers in chronic hemodialysis patients.", "results_summary": "CoQ10 supplementation was safe and well-tolerated, significantly reducing plasma isofuran concentrations in a dose-dependent manner, but did not affect F2-isoprostane levels.", "population_specificity": "Chronic hemodialysis patients", "effective_dosage": "Up to 1800 mg per day", "study_duration": "Not specified (short-term)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:19.775635+00:00"}
{"study_id": 62997, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to analyze the effects of CoQ10 supplementation on exercise-related parameters in healthy humans and clarify the current state of knowledge in this field.", "results_summary": "CoQ10 demonstrated bioenergetic and antioxidant properties, improving cellular energy production and preventing oxidative damage, making it suitable as a dietary supplement for enhancing bioenergetics and inhibiting age-related pathologies.", "population_specificity": "Healthy humans", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:23.004492+00:00"}
{"study_id": 62998, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the potential of autophagy and mitophagy inducers, including Coenzyme Q10, as a novel strategy to improve mitochondrial function in mitochondrial diseases and other disorders with altered mitochondrial metabolism.", "results_summary": "The abstract suggests that autophagy and mitophagy inducers may improve mitochondrial function, but emphasizes the need for deeper investigation into the molecular mechanisms to safely modulate these processes. Coenzyme Q10's specific effects are not detailed.", "population_specificity": "Patients with mitochondrial diseases and other disorders associated with mitochondrial dysfunction.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:24.046039+00:00"}
{"study_id": 63000, "supplement_id": 1036, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of CoQ10 supplementation on glucose homeostasis, lipid profiles, and biomarkers of inflammation and oxidative stress in patients with metabolic syndrome.", "results_summary": "CoQ10 supplementation significantly reduced serum insulin levels, HOMA-IR, and HOMA-B, and increased plasma total antioxidant capacity, though some effects disappeared after adjustment. No significant changes were observed in fasting glucose, lipids, or inflammatory markers.", "population_specificity": "Overweight or obese type 2 diabetes patients with coronary heart disease, aged 40-85.", "effective_dosage": "100 mg daily", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:25.452846+00:00"}
{"study_id": 62999, "supplement_id": 1036, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to determine if ubiquinol (reduced Coenzyme Q10) supplementation could mitigate simvastatin-induced liver injury by analyzing miRNA profiles and liver enzyme levels.", "results_summary": "Ubiquinol supplementation significantly down-regulated liver enzymes (alanine aminotransferase and alkaline phosphatase) and modulated miRNAs associated with apoptotic and inflammatory pathways, suggesting hepatoprotective effects. Simvastatin alone showed miRNA changes linked to liver injury, but 20 mg/day did not pose significant hepatotoxicity risk.", "population_specificity": "Simvastatin-treated patients in a double-blind, randomized-controlled trial.", "effective_dosage": "Not specified for ubiquinol (simvastatin dosage was 20 mg/day).", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:25.536378+00:00"}
{"study_id": 62989, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether supplementing a Mediterranean diet with Coenzyme Q10 (CoQ) provided additional benefits in reducing oxidative stress and AGEs levels compared to the diet alone.", "results_summary": "The study found that a Mediterranean diet reduced AGEs levels and improved redox-state parameters, and these benefits were further enhanced by CoQ supplementation, particularly in the postprandial state.", "population_specificity": "Twenty participants aged \u226565 (10 men and 10 women).", "effective_dosage": "Not specified.", "study_duration": "4 weeks per diet period (Med diet, Med + CoQ, SFA diet) in a crossover design.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:26.073472+00:00"}
{"study_id": 63001, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of selenium and Coenzyme Q10 supplementation on inflammatory biomarkers (CRP and sP-selectin) and their potential impact on cardiovascular mortality in elderly individuals.", "results_summary": "Active supplementation with selenium and Coenzyme Q10 significantly reduced CRP and sP-selectin levels, indicating anti-inflammatory and anti-atherosclerotic effects, and was associated with reduced cardiovascular mortality regardless of baseline biomarker levels.", "population_specificity": "437 elderly individuals", "effective_dosage": "Not specified", "study_duration": "48 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:26.687947+00:00"}
{"study_id": 63002, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of lifestyle interventions, including a supplement containing Coenzyme Q10, on prostate cancer progression and mortality.", "results_summary": "The study found that a trial supplementing soy, lycopene, selenium, and Coenzyme Q10 demonstrated beneficial effects on prostate cancer outcomes, with low risk of bias and high methodological quality.", "population_specificity": "Prostate cancer patients (3,418 total participants across 44 trials, median 64 men per trial).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:26.899427+00:00"}
{"study_id": 63003, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of oxidative/nitrosative stress in aging and MDD, and the potential therapeutic use of antioxidants like Coenzyme Q10 in MDD.", "results_summary": "The study found that MDD is associated with significantly lower concentrations of antioxidants, including Coenzyme Q10, suggesting a potential therapeutic role for such compounds in mitigating oxidative stress-related aging effects in MDD.", "population_specificity": "Individuals with major depressive disorder (MDD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:27.756629+00:00"}
{"study_id": 63004, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the effects of CoQ10 supplementation on cytokine generation and oxidative stress in rheumatoid arthritis patients.", "results_summary": "CoQ10 supplementation significantly reduced serum malondialdehyde (MDA) and suppressed overexpression of TNF-\u03b1, but did not significantly affect total antioxidant capacity (TAC) or IL-6 levels.", "population_specificity": "44 patients with rheumatoid arthritis (22 in CoQ10 group, 22 in placebo group).", "effective_dosage": "100 mg/day", "study_duration": "2 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:30.707141+00:00"}
{"study_id": 63005, "supplement_id": 1036, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the effect of Coenzyme Q10 and combined antioxidant therapy on oxidative stress markers in patients with non-proliferative diabetic retinopathy.", "results_summary": "Coenzyme Q10 significantly reduced oxidative stress markers (LPO and nitrites/nitrates) and improved antioxidant capacity (TAC, catalase, and GPx activity) compared to baseline and placebo. The results were statistically significant (P\u2009<\u20090.0001).", "population_specificity": "Patients with non-proliferative diabetic retinopathy under clinical management.", "effective_dosage": "Not specified in the abstract.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:32.609158+00:00"}
{"study_id": 63006, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to review the structure and function of CoQ10, its relationship with mitochondrial impairment and oxidative stress, and its potential therapeutic effects on neurodegenerative diseases.", "results_summary": "The abstract highlights CoQ10's role in electron transport and antioxidant activity, suggesting its potential for preventing neurodegeneration. It discusses its effects on Alzheimer's, Parkinson's, and Huntington's diseases but does not provide specific efficacy data.", "population_specificity": "Not specified (review article, not a clinical study)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:33.422327+00:00"}
{"study_id": 63007, "supplement_id": 1036, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of Coenzyme Q10 in cardiovascular disorders of ageing, focusing on its antioxidant properties and mitochondrial function.", "results_summary": "The study found that CoQ10 is safe and well-tolerated, with potential benefits in cardiovascular disorders such as chronic heart failure, hypertension, and endothelial dysfunction. Plasma CoQ10 levels were identified as an independent predictor of mortality in cardiac patients.", "population_specificity": "Patients with cardiovascular disorders of ageing (e.g., chronic heart failure, hypertension, endothelial dysfunction).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:33.659979+00:00"}
{"study_id": 63008, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the evidence level for Coenzyme Q10's effectiveness in migraine prevention in adults.", "results_summary": "The study found Level C evidence for Coenzyme Q10's use in migraine prevention, indicating modest or conflicting efficacy. No strong clinical outcomes were demonstrated.", "population_specificity": "Adults with migraine disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:33.922500+00:00"}
{"study_id": 63010, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether Coenzyme Q10 has disease-modifying properties in Huntington's disease.", "results_summary": "The study found that Coenzyme Q10 did not demonstrate disease-modifying properties in Huntington's disease, dashing earlier hopes. However, other agents showed potential safety or efficacy hints for further trials.", "population_specificity": "Patients with Huntington's disease.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:34.074688+00:00"}
{"study_id": 63009, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the evidence supporting Coenzyme Q10 as a preventive treatment for migraine based on expert consensus and available clinical data.", "results_summary": "Coenzyme Q10 received a strong recommendation for migraine prevention from the Canadian Headache Society, indicating it is supported by the best available evidence, favorable adverse event profile, and expert consensus. The abstract does not provide specific efficacy metrics but suggests it is among the recommended treatments.", "population_specificity": "Migraine patients (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:34.732998+00:00"}
{"study_id": 63012, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether Coenzyme Q10 could serve as a disease-modifying therapy for Parkinson's disease.", "results_summary": "The study reported negative findings or futility regarding Coenzyme Q10's effectiveness in modifying the disease process of Parkinson's. It did not demonstrate significant benefits in slowing neurodegeneration or stopping disease progression.", "population_specificity": "Patients with Parkinson's disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:35.264504+00:00"}
{"study_id": 63013, "supplement_id": 1036, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the efficacy and safety of a nutraceutical combination containing Coenzyme Q10 in reducing blood pressure and improving lipid profiles in patients with hypertension and hypercholesterolemia.", "results_summary": "The study found that the nutraceutical combination significantly reduced systolic 24-hour ambulatory blood pressure and pulse pressure, as well as total cholesterol, LDL-C, and triglycerides, while HDL-C remained unchanged. No adverse effects were reported, indicating the combination was safe and well-tolerated.", "population_specificity": "Patients with grade 1 essential hypertension and hypercholesterolemia, mean age 56.0 \u00b1 4.6 years, without history of cardiovascular diseases or organ damage.", "effective_dosage": "One tablet daily (containing Coenzyme Q10 among other ingredients).", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:40.838364+00:00"}
{"study_id": 63017, "supplement_id": 1036, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine the effectiveness of a multi-ingredient anti-aging moisturizer containing Coenzyme Q10 in improving facial skin appearance.", "results_summary": "The moisturizer showed statistically significant improvements in all clinical grading parameters by 8 weeks, with greater improvements at 12 weeks. Self-assessment and digital photography supported these findings, indicating favorable efficacy and aesthetic results.", "population_specificity": "37 female subjects aged 35-60 years.", "effective_dosage": "Not specified (part of a multi-ingredient moisturizer applied twice daily).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:41.754604+00:00"}
{"study_id": 63016, "supplement_id": 1036, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of CoQ10 supplementation on liver enzymes, inflammation status, and adipokines in patients with NAFLD.", "results_summary": "CoQ10 supplementation significantly reduced liver aminotransferases (AST, GGT), hs-CRP, TNF-\u03b1, and NAFLD grades, while increasing adiponectin levels. No significant changes were observed in IL-6 levels.", "population_specificity": "41 subjects with nonalcoholic fatty liver disease (NAFLD).", "effective_dosage": "100 mg once daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:42.014433+00:00"}
{"study_id": 63014, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the impact of statin therapy on plasma CoQ10 concentrations through a meta-analysis of randomized controlled trials.", "results_summary": "The meta-analysis found a significant reduction in plasma CoQ10 concentrations following statin treatment, consistent across all statin types (atorvastatin, simvastatin, rosuvastatin, pravastatin) and both lipophilic and hydrophilic statins. The effect was observed regardless of treatment duration (<12 weeks or \u226512 weeks).", "population_specificity": "Patients undergoing statin therapy (specific demographics not detailed in the abstract).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Trials included both short-term (<12 weeks) and long-term (\u226512 weeks) interventions.", "interactions": "Statins (atorvastatin, simvastatin, rosuvastatin, pravastatin).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:42.404111+00:00"}
{"study_id": 63015, "supplement_id": 1036, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to examine the role of oxidative stress in ALS patients by analyzing CoQ10 oxidation levels and to explore the potential benefits of combining CoQ10 with edaravone to reduce oxidative stress.", "results_summary": "The study found that ALS patients had increased oxidative stress, indicated by higher oxidized CoQ10 levels. Edaravone treatment improved some oxidative markers but did not reduce CoQ10 oxidation, suggesting potential benefits from combining CoQ10 with edaravone.", "population_specificity": "26 ALS patients compared to 55 age-matched healthy controls.", "effective_dosage": "Not specified for CoQ10 (edaravone dosage: 30 mg/day, 1-4 times weekly).", "study_duration": "At least 3 months (13 patients continued for 6 months).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:43.436611+00:00"}
{"study_id": 54966, "supplement_id": 1050, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate diagnostic methods and treatment efficacy for Wilson disease, a condition involving copper metabolism.", "results_summary": "The study found that medical therapy is effective for most Wilson disease patients, with liver transplant as a rescue option for severe cases. Regular monitoring of clinical, biochemical, and copper metabolic parameters is essential for treatment management.", "population_specificity": "Patients with Wilson disease or suspected Wilson disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:50.661667+00:00"}
